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ABSTRACT 
Seventy-six ambulatory women with a mean age of 68 years partici­
pated in a 12-month study of the effects of fluoride, with and without 
multivitamin and calcium phosphate supplements, on nutritional status 
including bone density. Mean daily nutrient intakes calculated from 
4- to 7-day weighed food intakes were 1519 kcal including 15% from 
protein and 36% from fat; others were 797 mg calcium, 1000 mg phosphorus, 
and 8.6 mg iron. Mean intakes by 59 women who were not receiving vitamin 
supplements were 5800 IU of vitamin A and 35 mg of ascorbic acid. Mean 
blood hemoglobin was 13.9 g/100 ml; serum calcium and phosphorus level 
means were 9.60 and 3.35 mg/100 ml, respectively. A mean of 1.92 mg 
of phosphorus was released by alkaline phosphatase, while the mean 
cholesterol level was 222 mg/100 ml. Mean serum levels of total protein 
and albumin were 6.77 and 3.67 g/100 ml, respectively, and the A/G ratio 
was 1.22. Plasma ascorbic acid averaged 0.34 mg/100 ml and serum 
vitamin A, 50.4 µg/100 ml for the women who were not receiving vitamin 
supplements. 
The mean bone density index of the left phalanx 5-2 was 0.819 g 
equivalents of alloy per cc of bone, while mean height and weight were 
156.3 cm and 65.4 kg, respectively. Canonical correlation showed an 
age-associated decrease in bone density, height, weight, and intake of 
protein, calcium, phosphorus, and ascorbic acid. 
The group of 76 women was divided into 4 groups, approximately 
equal in number, matched for bone density, age, and weight. Fluoride 
was administered at a level of 0.25 mg/kg body weight/day as a single 
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therapeutic agent to one group and in combination with 464 mg calcium 
and 360 mg phosphorus as calcium phosphate and 25, 000 IU vitamin A 
and 200 mg ascorbic acid in a multivitamin capsule to another group. 
The diets of another group of women were supplemented with 464 mg 
calcium and 360 mg phosphorus, while the diets of 19 of the women 
were not supplemented. Subgroups of 4 subjects from each experimental 
group participated in metabolic balance studies. Metabolic studies 
and bone density measurements were repeated after 4 months of supple­
mentation and all tests were repeated after 12 months. 
After supplementation, minor differences in nutrient intakes 
V 
and blood levels occurred in the groups receiving fluoride. Consumption 
of calcium decreased in the group which received fluoride, although the 
final mean intake was 761 mg per day. In the group receiving fluoride 
in combination with calcium pho.sphate and vitamin supplements, increases 
in plasma ascorbic acid and serum vitamin A and decreases in serum total 
protein, calcium, and phosphorus were obtained. Nevertheless, all 
values remained within normal ranges. 
Supplementat�on with fluoride alone resulted in a significant 
increase (10%) in bone density, and fluoride in combination with 
calcium phosphate and vitamins produced a 4% increase. Insignificant 
increases in bone density were observed when the diet was unsupplemented 
(2%) or supplemented with calcium phosphate (2.5%). 
Nitrogen balances remained positive throughout the study. An 
age-associated defect in calcium absorption was indicated in all 
experimental groups. Changes in neither calcium nor phosphorus balances 
correlated with those in bone density. Positive balances of these 
nutrients were shown when fluoride accompanied the supplements of 
calcium, phosphorus, and vitamins but bone density decreased in 2 
of the 4 subjects in that subgroup. All members of the balance group 
receiving fluoride alone exhibited negative balances of calcium and 
phosphorus while bone density increased. 
No adverse effects of fluoride supplementat�on were observed 
vi 
in any of the women during the study. The biological significance of 
a decrease in serum calcium has not been elucidated; a shift of serum 
calcium to bone, or a reduction in calcium mobilized from bone (possibly 
lowering serum calcium), may be advantageous. Increases in bone 
density in response to fluoride without alterations in dietary intake 
or blood constituents, other than serum calcium, tends to encourage 
further exploration of the prophylactic as well as therapeutic benefits 
of low-level fluoride supplementation. 
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CHAPTER I 
INTRODUCTION 
Aging is a physio�ogical process begi�h:i:ng· at conception and con­
� 
tinuing until dea_tho . The elderly person is not -only the product o{ his 
genetic inheritance, but also of the lifestyle he has established for 
himself through the activities he has chosen, food preferences he has 
cultivated, illnesses he has overcome, and a multiplicity of �ther 
phenomena. Longevity of women is greater than that of .men; _ thus more 
women live to experience the physiological, psychological, and social 
'· problems whi�h accompany old age. Some of .these maladies may result, 
i� part, from decreased nutrient· intakes, altered nutrient requirements, 
or impaired nutrient absorptiono 
Decreased bone·density and:a tendency for spontaneous fracture oc­
cur with -!ncr�asing frequency in women after .about age 50 years; however, 
it has been reported that loss of bone is of less magnitude and occurs 
less frequen�ly in individuals .in regions where the fluoride content of· 
the drinking water is higho_ 
In clinical cases, administration of {luoride at 1 mg/kg body 
--�e�ght/day has been consistently reported as both safe and beneficial in 
the treatment of bone diseases sue� as Paget's di�ease, multiple myeloma, 
and osteoporosiso 
-�� .this study, sodium fluoride was administered as a single. thera-· 
peutic agent to 20 elderly women and in combination with cal�ium phos­
phat_e an4 vitamins to a similar number of participants in an effort to 
1 
2 
increase bone density. For comparative purposes, calcium phosphate was 
provided for 17 participants and the diets of 19 women remained un­
supplemented. 
Bone density, nutrient intakes� blood constituents 11 ·and_ utiliza­
tion of calcium� phosphorus� and nitrogen were evaluated before and 
after 12 months of supplementation. In .addition, metabolic balances 
and bone density measurements were repeated about 4 months after sup­
plementation was initiated to ascertain any early.changes attributable 
to the supplementso. 
That dietary supplements such as.sodium fluoride, calcium phos­
phate, and multiple vitamins would aid in maintenance of normal bone 
density indices without causing undesirable �ide effects was the hypoth­
esis of this studyo The objectives of the study were: 
l e · To ascertain the nutritional status of a female geriatric 
populationo 
2 o To administer sodium fluoride at relatively low levels to a 
number of elderly women to test its effectiveness in increasing 
bone densityo 
3 o · To administer calcium phosphate and_ multiple vitamins with and· 
without sodium fluoride to delineate the separate effects of 
thes� supplements on bone densityo 
4" To assess whether or not the supplements have any other effects 
on nutritional status, including nutrient intake.and blood 
levels of sele�ted constituentso 
S o To study relationships between metabolic balances and bone 
densityo 
CHAPTER II 
REVIEW OF LITERATURE 
In formulating nutrition policy for the seventies� Watkin (1) 
recognized both short- and long-range objectiveso The short-range o�-
jective was to improve the status of those who are old; the long-range 
objective was to alter nutritional patterns and health of the young in 
such a manner that physiological aging and its accompanying disabili­
ties are deferred to the oldest possible age o 
Aging has intrigued man for centurieso Poets have eulogized age, 
historians have recorded it� families have worshipped it, and philos­
ophers have been humbled by ito Explorers have searched for a natural 
fountain of youth, medicine has been dedicated in ,its effort to permit 
mankind to attain old age, society has tried to adjust to the needs .of· 
the aged, and today, science is attempting to delineate the aging pro­
cesso Biochemists, ·biophysicists, physiologists, biologists, nutrition­
ists j and physicians (2) are spending. thousands of hours and dollars as 
they endeavor to isolate the causes of the changes� and to discover means 
for delaying these changeso 
Nutrient Intake 
The diversity of environmental conditions, economic situations, and 
personal food prejudices makes generalizations about .dietary intakes of 
aged 'individuals difficult o For example, nutrient intakes by elderly 
persons living in a retirement home which employed the services of a 
consulting dietitian had better nutrient intakes than those living in 
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their own homes (3); elderly hospitalized patients who were able to feed 
themselves generally had lower nutrient intakes than chronically ill 
patients who consumed the foods selected for them by staff members (4); 
and socially isolated older persons who lived alone� were unemployed j and 
ate most of their meals alone consumed lesser quantities of nutrients 
than did those·who were living with a.spouse, working past the retirement 
age, and eating with their .families (S)a Guggenheim and Margulec (6) 
found that food consumed by 49 women living alone was similar to that con­
sumed by 27 women living with their families; however, mean nutrient in­
takes, by the two groups, of energy, protein, calcium, iron, vitamin A, 
and ascorbic acid met the Recommended Dietary Allowances (7) only at the 
50th percentileo 
Decreased nutrient intake with advancing age is generally recogniz­
ed o In the San Mateo study, Steinkamp et alo (8) reported significantly 
reduced intakes of calories, protein j calcium, iron, vitamin A, ascorbic 
acid, and the B vitamins after age 75 0 In�akes of animal protein were not 
decreased with increasing ageo Swanson (9) reported� from a survey of 
1072 women aged 30 to 90 years� a downward .trend in intakes of energy j 
protein, and calcium; Fry et alo (10), after studying both weighed (by 
6 women) and recorded (by 26 women) food consumption� also reported a 
downward trend with inc�easing age in intake of all nutrients except cal­
cium and riboflavin o From dietary records obtained for 252 men aged 20 
to 99 in the Baltimore Longitudinal Study, daily intakes of energy, pro­
tein,·fat, calcium, iron� vitamin A� and the B·vitamins decreased with 
increasing age; intakes of ascorbic acid increased as age increased (ll)a 
From 7-day records of food consumption kept by 2808 women aged 30 to 80 
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who participated in the nutritional status studies of the 1950's (1?), 
decreased intakes of energy, protein, calcium, iron, ·an� the.B vitamins 
with advancing age were showno Lyons and Trulson (13) have reported 
that one�fourth of the 100 men and women aged 65 and .over� who partici­
pated in a nutrient intake·study p were consuming less than 75% of the 
recommended allowance for energy, riboflavin, iron, and ascorbic acid o 
The recent Ten-State Nutrition Survey (14) revealed that in the popula­
tion surveyed, persons 60 years of age and older consumed insufficient 
food to meet recommended allowances o Elderly persons living in the low 
income-ratio states (Kentucky, Louisiana, South Carolina, Texas, West 
Virginia) had lower dietary intakes than those in high income-ratio 
states; however, dietary intake was not closely related to income. 
Males were found to consume more nutrients than females and Blacks to 
consume less than Whitesc Body weight and nutrient intake were consist­
ently relatedo 
'Biochemical Studies 
A survey of research on serum vitamin A, carotene, and ascorbic 
acid levels in the aged population failed to yield significant variation 
with age (15)o Brin et alo (16), from a nutritional status study of 
234 elderly men and women, reported a mean plasma ascorbic acid of Oo84 
mg/100 ml for··women; no mean.for serum vitamin A was calculated, but 58% 
of the women had serum levels of vitamin A greater than 58 µg/100 mlo 
Brewer et al o (17) reported greater variability in hemoglobin and .serum 
vitamin A concentrations in persons past 50 years of age than in younger 
persons.although the means appeared to be within the range of normalo A 
mean serum protein concentration of 7o13 g/100 ml was wi�hin the range 
of normal. 
In the Ten-State N�trition Survey (18), hemoglobin values in­
creased in women past childbearing age but remained lower than those, 
for meno Serum albumin and total protein were within the lower limits 
of normalo Serum vitamin A levels _increased with age o Some deficient 
and low values for serum ascorbic acid were observed in.the elderly. 
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Mineral absorption studied using isotopes of calcium decreased 
with advancing age (19), although Smith et al o (20) could detect no 
indication of impaired absorption except in one group of diagnosed os­
teoporotics aged 61 to 70 yearso Avioli et alo (19) found· no difference 
between calcium absorbed by the osteoporotic and.the normal., 
No changes in collagen metabolism as indicated by urinary hydroxy­
proline excretion were observed in osteoporotic and non-osteoporotic aged· 
persons when compared with normal young adults (21). Data from balance 
studies reported by Ohlson et alo (22) indicate that the need for protein 
and.calcium is not decreased with ageo 
Recommended Dietary Allowances for the Aged 
The National Research Council's reference woman for which adult 
dietary allowances are recommended is 22 years old and weighs 58 kgo 
The environment .in which she lives has a mean temperatu�e of .20 ° and 
she is of normal activity (7)o 
The dietary allowances for a woman 55 years of age or older.dif­
fers little from that recommended by the Nationa� Research Council for a 
woman 22 years of age� The allowance for iron is lowered for the post-
7 
menopausal yearso The caloric allowance is reduced in keeping with the 
approximate decline of basal metabolism rate and reduction in physical 
activityo The dietary allowance per day is thus: 1700 kilocalories, 
55 g protein, 5900 IU vitamin A� 25 IU vitamin E� 55 mg ascorbic acid, 
Oo� mg folacin, 13 mg equivalents niacin, l o 5 mg riboflavin� loO mg 
thiamin, 2.0 mg vitamin B6� 5 µg vitamin B12, 800 mg calcium, 800 mg 
_phosphorus, 80 µg iodine, 10 mg iron, and 300 mg magnesium (7)o 
Bone Density 
The skeletal system exhibits changes with advancing ageo Frost 
(23) has indicated that up to 40% of the skeleton is lost between youth 
and old age. That the changes are undesirable is supported by the work 
of Iskrant and Smith (24) from which the authors estimated that of the 
one million fractures experienced annually by women over 45 years of age 
700,000 were incurred by those with bone densities so low that they were 
classified as osteoporotic o Gitman and Kamholtz (25) have determined 
that 65 0 8% of the women over 65 have radiographically manifest osteoporo­
sis� Guggenheim et al o (26) detected some degree of osteoporosis in 94% 
of the women over age 60 examined in Jerusalem o The literature is in 
good agreement that, not only does bone density decrease with age j but 
also the fifth decade is the usual time of onset (27, 28 j 29� 30, 3l)o 
From rather extensive studies involving radiographic bone measure­
ments from more than 15,000 subjects (26, 27, 32, 33), it is evident that 
women lose bone more rapidly than do meno For example, Garn et alo (27) 
found the loss of bone to occur twice as fast in women as in meno Re­
duced bone density in old age is not peculiar to any one populatio�, 
race, or geographical area, although variations in frequencies are ob­
served. Nordin (34) found bone loss to start earlier among Japanese 
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and Indian women than in British or American women. Chalmers and Ho (35) 
reported a higher incidence of hip fracture in women from Sweden than in 
those from Great Britain, China, or Africa (Bantu). Blacks have bones 
which are more dense than Whites (32) and Moldawer et al. (36) found 
the incidence of compression fracture to be greater in Whites than Blacks. 
Engh et al. (37) reported that fracture due to minimum trauma is great­
est in Whites residing in institutions. 
The entire female skeleton apparently loses bone at about the same 
rate. Analysis of bone from cadavers (32) showed that the density 
(weight/volume) of long bones from a skeleton did not differ from one 
another. Dequeker et al. (38) found that changes in the second meta­
carpal paralleled those occurring throughout the skeleton. Nordin (39) 
has recently reported that the loss of trabecular bone is greater than 
that of cortical bone. Smith and Walker (40) previously observed that as 
cortical thickness decreased, the diameter at the midshaft increased. 
Reduction of bone density with advancing age is accepted as a widespread, 
or perhaps universal, phenomenon. It has been suggested (41) that once 
bone loss begins, the average amount of bone diminishes linearly with age 
and values for the amount of bone at each age have a normal distribution. 
It was also suggested by Newton-John and Morgan (41) that since no great­
er variation in the amount of bone appeared in the aged than in youth, 
classification of an osteoporotic group within the aged population was 
not justified. Goldsmith et al. (42) found that osteoporotic women lost 
bone mass before the fifth decade but in the succeeding three decades, 
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the non-osteoporotics lost mineral twice as rapidly as did osteoporotics 0 
By the eighth decade the two populations could not be distinguished from 
each other Q 
A longitudinal study was conducted by.Adams et al a (43) in which 
second observati9ns were made 11 years af�er the first o At ·the time of 
the first measurements the age range was 55 to 64 years o Bone loss of 
the second metacarpal was shown to be characteristic of the individual. 
Although there was an.overall loss of bone in both sexes, some individ­
uals lost little or no boneo Women tended to lose bone at a faster rate 
than men o While backache, loss of height, and fractures of the verte­
brae and long bones have been identified as clinical symptoms of osteo­
porosis, the authors-could not equate reduced bone density with the 
clinical symptomsa Tillinghast (44) found that demineralization of 
spinal bone frequently occurred without associated pathology o 
Formation and Remodeling of Bone 
Bone remodeling occurs throughout life in .foci of the cortex and 
trabeculae o It appears to be greatest in infancy and lowest in the fourth 
decade (4s)· o With aging, osteoporosis which is characterized by a reduced 
amount.of bone-tissue per unit volume of bone frequently occurs o Although 
reduced in quantity, th� bone appears normal in its chemical composition 
- (46, 47) o Where bone is formed, osteoblasts that participate in .the syn­
thesis of matrix are found o Os�eocytes _develop from osteoblasts and have 
nuclei with prominent nucleoli and cytoplasm with well-formed Golgi zones 
indicating that they are active cells o Formation of collagen takes place 
close to the osteoblastso Nutrients cannot diffuse easily through dense 
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bone although it is necessary that nutritive flow to the osteoblasts be 
maintainedo The Haversian system of canals or tunnels which contains 
mesenchymal cells (osteons), nerves, and blood vessels provides a 
passage-way through which nutrients can diffuseo The average number of 
osteoblasts, the average rate at which each makes new bone matrix 
and the average functional lifetime of the osteoblasts change little 
with age (48)e Osteoclasts are giant multinucleated cells which partic­
ipate in the resorption of bone o The Haversian systems .are formed and 
reconstructed by the erosive action of osteoclastso Thus in response 
to a stimulus, undefined at present, there is proliferation of osteons 
into osteoclasts for the initiation of bone resorptiono Resorption sub­
sides after about two months and osteoblasts appear and .begin to con­
struct new bonee About three months are required to replace the bone 
removed by the osteo.clasts (23) .. 
Bone remodeling is a complex phenomenono At present, there is no 
clear-cut explanation for decreased bone·density with ageo Trabecular 
bone which is covered with endosteal (bone resorbing) surfaces is lost 
faster than is cortical bone when bone formation occurso Decreased bone 
density of the vertebrae may be detected earlier than in the extremities 
because the ·endosteal surface-to-bone-volume ratio is · higher for tra­
becula than for cortex (23)o If » as concluded by Rodan.and Anbar (49), 
remodeling is regulated by the turnover of matrix, reduced bone density 
and osteoporosis may be attributed to disease of the matrix as reported 
by Shapiro (50) o Other work (51) indicates an.increased synthesis of. 
proteolytic enzymes in bone.with aging .. Keating et al o , (52) have-found 
that serum calcium levels in men are reduced with aging while in.women 
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high levels are maintained at the expense of bone calcium. Jowsey (53) 
has suggested that decreased bone density may result from the efforts 
of the ·body to maintain serum calcium. Hypocalcemia has been asso­
ciated with formation and mineralization of bone matrix (54) o 
Long-term exposure to water-borne fluoride has been associated 
with increases in bone mineral (55, 56). Epker (57) found that in dogs, 
high levels of fluoride promoted active bone formation and thus counter­
acted the loss of cortical-bone with aging. It _was further shown in 
rats (58), that fluoride decreased the ease with which the skeleton 
could be induced to undergo resorption o Human biopsies from three 
patients receiving fluoride therapy showed new bone formation (59) o 
However, in the absence of sufficient calcium and vitamin D, the new 
bone was not calcified. Zipkin (60) detected a homeostatic deposition 
of fluoride in bone; smaller bones of rats pair-fed at 60% of the con­
sumption of control animals retained more of the fluoride than did the 
controls fed ad libitum. Phosphate supplementation increased the porosity 
of rabbit tibiae and also resulted in soft-tissue calcification (6l)o 
Several studies are reported which show a relationship between nutritional 
status and bone density. Meema and Meema (62) found osteoporosis to be 
most prevalent among old, non-diabetic women with low body weighto Nordin 
(39) observed that the incidence of osteoporosis is lowest where the avail­
ability of calcium is highesto 
Interrelation of Diet and Bone Density 
With radiographtc and histological evidence that bone density de­
creases with age and that clinically diagnosed osteoporosis increases 
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with age, numerous studies have been conducted ·in.an attempt to explain· 
and correct the phenomenono Researchers have attempted to interrelate 
several of the parameters including dietary intake, metabolic balances, 
se�um levels of nutrients� urinary constituents, bone density, and bone 
morphologyo Several species including humans have been utilized in 
experimental studies. 
In humans, low bone density was found to be associated with a low 
product of serum calci�m times serum phosphorus, low vitamin D intake, 
and elevated serum alkaline phosphatase o Nutrient intakes of those with 
low bone densities did not always differ from those with high densities 
(63). 
In a Bantu male population where intake of inorganic iron was ex­
tremely high due to consumption of alcoholic beverages prepared in iron 
kettles, a significant inverse correlation between bone mineral density 
and the concentration of iron stored in the liver was observed o Increas­
ed·bone resorption space was observed in the osteoporotic Bantu subjectso 
Subsequent studies with guinea pigs showed that an iron overload reduced 
the hepatic concentration of ascorbic acid and decreased the percentage 
of bone forming surface as well as increasing areas of bone resorptiono 
Injection of ascorbic acid prevented these changes in bone (64)o 
Protein-calorie deficiency induced in pigs resulted in a reduced 
rate of proliferation and maturation of cartilage and decreased osteo­
blastic activity; in addition, generalized rarefaction of the bone oc­
curred (6S)o In·rats mainta�ned on a low-protein diet, decreased radio­
graphic density of bone was observed (66)0 
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In three patients with osteoporosis, calcium balances were slight­
ly negative during periods of low calcium intake (67) o Long-term cal­
cium supplementation failed to improve the calcium balance to the extent 
it was.achieved in non-osteoporoticso Fecal excretion of calcium was 
higher in osteoporotic than in non-osteoporotic patients o Radioisotope 
data revealed that little of the calcium excretion was endogenous o The 
authors concluded that osteoporotics have poor absorption of calciumo 
In.other studies, Spencer et alo (68) reported that addition of calcium 
to low-calcium diets of persons with osteoporosis resulted in positive 
calcium balances·without altering phosphorus or nitrogen balanceso When 
sodium fluoride was given to nine patients for 22 to 42 days, 47cal­
cium absorption studies revealed that intestinal absorption of calcium 
and the calcium balances did not increase (69)o 
Addition of fluoride to the diet of monkeys increased the accre­
tion rate of calcium and the size of calcium pool in animals maintained 
on.an adequate protein diet o When added to low-calcium diets, fluoride 
promoted increased retention of dietary calcium and phosphorus (70)o In 
eight patients with osteoporosis, fluoride improved their balances of 
both phosphorus and nitrogen but failed to alter calcium retentiono 
Kinetic studies showed that fluoride reduced the exchangeable calcium 
without reducing bone formation (71)o 
Therapeutic Dietary Regimens for Reducing Bone Loss 
Osteoporosis has been associated with diets consistently.low in 
calcium (72, 73,. 74) o The earliest therapy for osteoporosis consisted of 
t�e ·administra�ion of calcium salts o Loss of calcium from bone after 
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menopause has been related to elevated levels of ._calcium in serum and 
urine (75). Failure by osteoporotics to reduce urinary calcium in re­
sponse to a diet low in calcium has been reported (76, 77)- o In ·fact, 
only at high levels of dietary calcium (40 mg/kg body weight) was more 
calcium retained by osteoporotics than by controls (78) o 
Recently, case studies of osteoporotic patients treated with 
sodium fluoride have been described (79, 80, 81, 82) o In a study 
reported by Higgins et alo (79) two of three patients on sodium fluoride 
supplements of 60 mg/day for 1 to 4 months experienced relief from 
pain although there were no changes in calcium,.phosphorus, or nitrogen 
balanceso In _four osteoporotic patients treated with sodium fluoride 
at levels ranging from 0.15 to lo7 mg/kg body weight/day, bone biopsies 
taken after 7 to 30 months showed that new bone was formed but remained 
uncalcified unless calcium and vitamin D were administered concurrently 
(59, 82). Both an increase in bone density and retention of calcium 
were achieved within two years by a patient on 88 mg sodium fluoride/day 
(80)o Some calcium retention and increases in bone density were expe­
rienced in patient� treated with 10 to 66 mg fluoride/day for about a 
year (81), especially where the supplements included vitamin Do 
In 11  patients administered sodium fluoride at �Oto 90 mg/day in 
addition to calci�m and vitamin D for one year, Jowsey et alo (83) report­
ed an increase in new bone formation in patients receiving at least 45 
mg sodium fluoride/day while 600 mg calcium/day decreased bone resorptionc 
Only Rose (84) failed to observe clinical remission with fluoride sup­
plementationo 
CHAPTER III 
EXPERIMENTAL PROCEDURE 
Io GENERAL PLAN 
Seventy-six ambulatory women, aged 41 to 84, residing at Eastern 
State Psychiatric Hospital in Knoxville, Tennessee, were participants 
in this studyo Medical records of potential subjects were screened 
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for presence of any chronic illness such as cardiac problems, diabetes, 
or malignancyo Participation was permitted with the approval of the 
individual, the clinical director of the hospital, and the person's 
nearest living relative or her legal guardian (Appendix A) o A phys­
ical examination by one of the hospital's physicians preceded the study 
and the participants were under constant surveillance by the hospital 
staffo 
Sixty women were housed in three dormitories while 16 lived in 
home-like cottages for all or part of the study o Sixteen women j rep­
resentative of the entire group but housed in one wing of a dormitory, 
were selected for 7-day·metabolic balance studieso Evaluations of 
dietary intake, selected blood constituents, an�hropometric measurements, 
metabolic balances, and bone density were made in the initial phase of 
the studyo Nutrient intakes of some of the women were supplemented with 
vitamins, calcium phosphate, and sodium fluorideo The initial measure­
ments were repeated on 60 subjects. after 12 months of supplementatione 
In addition, metabolic balances and bone density measurements were ob­
tained after the first four months of supplementationo Twelve of the 
15 
16 
16 selected for metabolic balance studies were available to participate 
in all three of the collection periods.  
Most women ate their meals in one of the hospital cafeterias o 
Each participant consumed those foods she chose from her plate which 
was served on a cafeteria lineo In the home-like cottages, each woman 
was permitted to serve herselfo Menus were planned by a registered 
dietitian employed by the hospital and no changes were made in the 
hospital menus. Food preparation was under the direction of a food 
service supervisor. 
After the initial tests, each woman was assigned to one of four 
experimental groups . Subjects in each group were matched for bone 
density, ·age, and weight. Group 1 (19 women) received no vitamin or 
mineral supplements . Group 2 (17 women) was continued on a vitamin 
capsule (Table 1) which had been prescribed by the hospital medical 
staff and calcium phosphate (Table 2) in wafer form daily was addedc 
Twenty women in Group 3 were given fluoride1 as its sodium salt in 
capsule form at the level of Oo 25 mg F/kg body weight/dayo To achieve 
a range as narrow as possible from the level of O o 25 mg F/kg body weight/ 
day, some women received the supplement for only six days per week (Table 
3) o Twenty �omen in Group 4 received a vitamin capsule and calcium 
phosphate as administered to Group 2 and sodium fluoride as given to 
Group 3 o Four women assigned to each group participated in the met­
abolic studieso 
1navies Rose Hoyt, Pharmaceutical Division of the Kendall Companyo 
Needham, Mass o Obtainable in increments of 5 mg fluoride. 
TABLE 1 
COMPOSITION OF VITAMIN SUPPLEMENT
! 
Daily 
Vitamin A palmitate (USP units) 25,000 
Vitamin D (USP units) 400 
Thiamine mononitrate (mg) 10 
Niacinamide (mg) 100 
Riboflavin (mg) 10 
Pyridoxine hydrochloride (mg) 5 
d-a-tocopheryl acid succinate (IU) 15 
Cyancob�lamin (µg) 5 
Calcium panothenate (mg) 20 
Ascorbic acid (mg) 200 
1
rnterstate Drug Exchange, Plainview, L. I. , N.Y. One capsule 
daily. 
TABLE 2 
COMPOSITION OF CALCIUM PHOSPHATE SUPPLEMENT
! 
Daily 
Calcium (mg) 464 
Phosphorus (mg) 360 
Vitamin D
2 
(USP units) 400 
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�bbott Laboratories, North Chicago, Ill. Dibasic calcium phos­
phate, hydrous, 1 g in wafer form twice daily. 
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TABLE 3 
INDIVIDUAL FLUORIDE SUPPLEMENTS 
Identification Body Weight Fluoride 
Number (kg) (mg) Frequency 
01 71. 9 20 Mon.-Sat. 
03 60.4 15 Daily 
04 48.4 15 Mon.-Sat. 
05 85.2 20 Daily 
06 46.1 15 Mon.-Sat. 
09 56.4 15 Daily 
10 45.4 15 Mon.-Sat. 
18 36.8 10 Daily 
23 57.6 15 Mon.-Sat. 
27· 69.5 20 Mon.-Sat. 
29 95.6 25 Daily 
31 38.2 10 Daily 
35 75.4 20 Daily 
37 42.5 10 Daily 
40 69.4 20 Mon.-Sat. 
41 69.6 20 Mon.-Sat. 
47 56.3 15 Daily 
54 76.0 20 Daily 
55 so.a 15 Mon.-Sat. 
56 61. 7 15 Daily 
59 74.3 20 Mon.-Sat. 
60 72.7 20 Daily 
61 71. 8 20 Mon.-Sat. 
65 79.7 20 Daily 
69 99.0 25 Daily 
71 54.0 15 Mon.-Sat. 
75 50.9 15 Mon.-Sat. 
77 51.5 15 Mon.-Sat. 
79 48.6 lS Mon.-Sat. 
81 61. 5 15 Daily 
83 67.0 20 Mon.-Sat. 
84 76.3 20 Daily 
87 132.3 30 Daily 
88 65.1 20 Mon.-Sat. 
90 77. 7 20 Daily 
92 111.3 30 Daily 
93 56.1 15 Daily 
94 95.0 25 Daily 
96 90.5 25 Mon.-Sa:t. 
99 57.7 15 Daily 
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!Io COLLECTION METHODS 
·Dietary Information 
Food served to each woman was weighed to the nearest gram on a, 
top-loading balance as each item was placed on the plate o The weight 
of each unconsumed portion of food was obtained and the quantity con-' 
sumed was calculated by-difference {Appendix B) . Average-daily consump­
tion was based on intakes for four to seven consecutive dayso The av-. 
erage daily nutritive intake of energy, protein, fat, calcium, phos­
phorus, iron, vitamin A, and ascorbic acid was obtained for each 
individual {85)o Careful records of snacks consumed during the dietary 
studies were kept and included in the day's nutrient intakeo During 
the 7-day balance studies, a sample of each snack item and•each food 
served was immediately frozen in airtight plastic cartons for analysis of 
nitrogen, calcium, and phosphoruse 
Urine and Feces 
To assist with urinary and fecal collections, a.technician was 
available 24 hours/day at each restroom on the ward where the metabolic 
study was carried out o Those few women who left the ward were reminded 
to return to the ward to use the bathroomo Excreta were ·collected in 
plastic bowls lined with plastic collection bags and inserted into the 
toilets o Urine was removed from the collection b�g to a 4 liter, 
acid rinsed container� At the end of each 24-hour period, the urine was 
mixed thoroughly and its volume was measured in a_stoppered graduated 
cylinder a A 5% aliquot was removed 9 added to th� composite, and frozen 
immediately for later determination of nitrogen, calcium, phosphorus 
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and hydroxyproline o In -addition, approximately 5 ml of each daily col­
lection was frozen separately for daily creatinine determinations o Feces 
was retained in the collection bag and inserted into a plastic carton 
for inunediate freezing on the cold plate of a freezer o After the feces 
was frozen to a solid state � it was transferred from the collection bag 
into a large plastic carton and the composite was stored at -10 ° 0 
Blood 
Fasting blood samples, 25 ml, were drawn by a registered nurse o 
Approximately 10 ml was immediately transferred from the syringe to an 
oxalated test tube. Oxalated tubes were prepared by placing O o l ml of 
a 10% potassium oxalate solution (w/v) into each test tube, dispersing 
it evenly in a thin layer around the tube, and drying at 90 - 100 ° (86) 0 
Blood was mixed with the potassium oxalate by corking the tubes and gen­
tly but rapidly inverting them o The remaining 15 ml was removed from 
the ·syringe to a test tube and permitted to coagulate o Hemoglobin was 
determined on the uncoagulated blood sample o Separation of both plasma 
and serum was accomplished by centrifugation in an International Clinical 
Centrifuge at 1500 x g for 10 minutes o Plasma and serum were removed 
with dropping pipettes o Plas�a ascorbic acid levels were determined im­
mediatelyo One ml samples of serum for determination of alkaline phos­
phatase activity were .set in an ice bath o The remaining serum tubes were 
stoppered and . placed in larger tubes for freezing o They were packed in 
ice for transport to the laboratory within an hour o Syringes were washed, 
packaged in sterile envelopes, and autoclaved at 120 ° for 20 minutes o 
Disposable sterile needles were used o Blood samples from 6 to 10 patients 
were ·drawn per day o 
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Anthropometric Measurements 
The height and weight of each participant were obtained o If shoes 
other than flat slippers were worn, height was corrected for heels o Each 
subject was encouraged to stand as tall as possible , looking straight 
ahead , while the measurement was taken o Sweaters or jackets were removed 
before weight was recorded o 
Bone Density Measurements 
A bone densitometer, developed by the Department of Nutrition in 
the College of Home Economics at The University of Tennessee, Knoxville, 
was used to estimate bone densityo The instrument utilized x-ray energy 
to scan the left phalanx 5-2, as the hand was automatically moved through 
a collimated x-ray beam o Linear absorption curves were traced directly 
onto graph paper for anteroposterior and lateral finger positions o A 
trace of the alloy standard was superimposed on the lateral tracing and 
a bone density index was calculated from measurements of these tracings 
(87 ) 
III. ANALYSIS OF FOOD, FECES, AND URINE 
Ashing 
Fecal and urine composites and samples of food consumed during the 
metabolic balance periods were stored at -10 ° in sealed polyethylene car­
tons until they could be analyzed o Sample preparation included blend­
ing an equal weight of hot di�tilled water .with feces and blending one 
entire serving of each food to a homogenous masso 
Duplicate aliquots of all foods, feces, and urine were placed in 
Coors #6 crucibles o Either 1 or 2 g of food was ashed depending on 
22 
the predicted quantity of calcium and phosphorus in the food (85) o Two 
g of the fecal slurry (1 g feces) or 3 ml aliquots of urine were dried 
for approximately 12 hours under a heat lamp. Ashing was carried out 
in a muffle furnace at 550 ° for 20 hourso The furnace was allowed to 
cool . between ashings o 
After . removal from the furnace, each sample was moistened with 1 
ml of demineralized water and then was dissolved in .4 ml of concentrated 
hydrochloric acid (2 ml was used when the final volume was to be 50 ml) o 
Each sample was treated for silica (88) by evaporation to dryness over 
water, _followed by contin�ed heating over water for 1 hour o After treat­
ment for silica, the ash was again moistened with _ l ml of demineralized 
water and dissolved in 6 ml of concentrated hydrochloric acid (3 ml was 
used when the final volume was to be 50 ml) . 
Ashes were dissolved over low heat; food ashes were transferred to 
either a 50 or 100 ml volumetric flask depending on the predicted quantity 
of calcium and phosphorus in the food (85) o Fecal and urine ashes were 
diluted to 100 mlo Polyethylene bottles were used for storage of the ash . 
solutionso 
Acid Rinsing 
Polyethylene bottles used for storage of the ash solutions and all 
glassware utilized in ashing and in calcium and phosphorus analyses were 
rinsed for 30 minutes in a dilute hydrochloric acid solution (1 part con� 
centrated hydrochloric acid and 9 parts water)o 
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Instruments 
In all analyses, unless otherwise specified, the International 
Centrifuge Model SBB #50092 H was utilized for centrifugation and the 
Beckman Model B Spectrophotometer was used for determination of sample 
absorbances o The Perkin-Elmer Atomic Absorption Spectrophotometer Model 
303 was used for determination of sample transmittance o  Absorbance was 
obtained by referring each transmittance to a table of absorbances which 
was prepared to accompany the instrument Q 
Calcium 
Aliquots of ash solutions from food, feces, and urine were diluted 
with lantpanum oxide to depress the interference of phosphorus , and cal­
cium was determined by atomic absorption spectrophotometry (89)o 
Reagents 
l o Calcium stock standard, O o 5  mg/ml: 0 0 3121 g Ca2co3 was diluted 
to 250 ml with water after. ! ml concentrated HCl had been added to enhance 
solubility of the Ca2co3 o 
2 o Calcium working standard, O o 05 mg/ml: 10 ml of the stock stand­
ard was diluted to 100 ml with watero 
3 o Lanthanum oxide i 5%: 5 o 9 g La2o3 was mixed with about 50 ml of 
water in a 100 ml volumetric flask o Twenty-five ml of concentrated HCl 
was added and the contents of the flask were cooled before being diluted 
to volume with water o The solution was filtered and used within 1 hour 
after preparation o 
----Method o Duplicate aliquots of ash solutions from food, feces, or 
urine estimated to contain between O o 02 and ·o o lO mg calcium (85) were 
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placed in acid rinsed 15 x 125 mm test tubes and water was added to a 
volume of 9 mlo Standards were prepared from the working standard to 
contain 0 . 00 to O o lO mg calcium and diluted to 9 ml· with water o The 
lanthanum solution was prepared and 1 ml was added to each sample and 
standard o M ixing was by mechanical mixer o Calcium was aspirated into 
an acetylene flame and determined at 420 0 2 nm with an atomic absorption 
spectrophotometer equipped with a calcium-zinc lamp . Absorbances (A) 
were referred to a standard curve from which the quantity of calcium 
in each sample was determined o 
Calculationso 
dilution mean daily urine volume 
mg Ca/day = mg Ca/sample x factor x or mean daily weight of 
food or feces 
Phosphorus 
Phosphorus in the ash solutions of food, feces, and urine was react­
ed with ammonium molybdate and sulfuric acido The phosphomolybdic acid 
thus formed was reduced by N-phenyl-P-phenylenediamine monohydrochloride 
with the development of a blue color which was measured with a spectro­
photometer (90) o 
Rea__g_ en ts 
l o P�osphorus stock standard , 1 mg/ml: 438 0 1  mg of KH2Po4 was 
dissolved and - diluted to 100 ml with watero 
2 o .. Phosphorus working standard , 10 µg/ml : 1 ml of the stock 
standard was . diluted to 100 ml with watero 
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3 o  Sulfuric acid, 5 N :  138 ml concentrated H2 so4 was added very 
slowly. to about 750 ml water in a liter flask o After cooling, the solu­
tion wa� diluted to volume with water e 
4 o . Ammonium molybdate � 0 0 025 M :  30 o 9  g (NH4)6Mo7o24 ° 4H20 was 
diluted with water to 1 liter with the inclusion of 1 ml concentrated 
H
2
�04 to facilitate solubilityo It .was stored in a polyethylene con­
tainer . 
S o  N-phenyl-p-phenylenediamine monohydrochloride (PPD)2, O o5% in 
1% sodium bisulfite : 50 _ mg PPD was moistened with 95% ethanol followed 
by about · SO ml water and 1 g NaHS03 before the solution was diluted to 
100 ml with water. It was filtered into a brown bottle for storage o 
Methodo Duplic�te quantities of ash solutions estimated to con­
tain 2 to 10 µg phosphorus (85) were placed in 12 x 100 spectrophoto­
meter tubes o The volumes were diluted to 1 ml with water. Standards 
were also prepared to contain O to 10 µg of phosphorus in 1 ml. One ml 
of 5 N sulfuric acid was added to each sample and standard followed by 
the addition of 1 ml of 0 0 025 M ammonium molybdate o The tube contents ­
were mixed with a mechanical mixer both before and after the addition of 
2 ml of PPD o Color was permitted to develop for 10 minutes prior to 
determination of the absorbances (A) on a spectrophotometer at 770 nm o 
Calculations o 
dilution mean daily urine volume 
mg P/day = . µg P/sample x factor x or mean daily weight of 
food or feces 
cone of . std 
Where : µg P/sample = A of sample x A of std 
2Eastman Organic Chemicals j Rochester, N o Y c  Catalogue #2043 0 
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Nitrogen 
A macro-Kjeldahl method was used for determination of nitrogen . in 
food, feces,.and urineo · After digestion, the annnonia was distilled, 
collected in boric acid, and titrated with Oo l N hydrochloric acid (9l) o 
All analyses were done in triplicate o 
Reagentso 
lo Sodium sulfate : Na2S04. 
2o Concentrated sulfuric acid : H2so4 o 
3o Cupric sulfate : Cuso4 o 
4 o  Hengar crystals o 
So Sodium hydroxide , 50% : 500 g of NaOH was dissolved in 750 ml 
water in an ice bath . 
6 0  Boric acid , 4% : 40 g of H3Bo3 was dissolved in 1 liter of 
water with heating o 
7 o Hydrochloric acid, Oo l N :  8 a 3 ml of concentrated HCl was 
diluted to 1 liter and standardized o 
Bo Methyl red - methylene blue indicator : 2 parts of . O o 2% 
alcoholic methyl red was mixed with 1 part of O o 2% alcoholic methylene 
blueo 
Method o Analyses were performed on samples of blended food es­
timated to contain 10 to 15 mg nitrogen j on 3 ml samples of urine, and 
on 1 g samples of fecal slurry o Food homogenates and fecal slurry samples 
were weighed in small paper cups and the cup with its contents was placed 
in a Kjeldahl flask o The blank determination for the food. and fecal sam- . 
ples included a paper cup o · Liquid foods and urine were pipetted directly 
into the Kjeldahl . flasks o To each flask was added 5 g sodium sulfate ) 
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20 ml concentrated sulfuric acid, 0 .3 g cupric sulfate, a Hengar crystal, 
and 2 glass beads . Flask contents were .digested until the solutions were 
clear and then they were cooled for approximately 30 minutes o The digests 
were diluted with 200 ml of water i mixed well , and again cooled o . Fifty ml 
of 50% sodium hydroxide was poured down the side of ·the flask so that it _ 
layered under the digest but did not mix prior to connection of the flask 
with the condenser and its placement on the distilling rack o The flask 
contents were swirled to mix, the burners ignited, and the nitrogen col­
lected in Erlenmeyer flasks containing 50 ml of 4% boric acid and methyl 
red-methylene blue color indicatoro The contents of each flask were ti­
trated back to their original shade of purple with standardized hydrochloric 
acid o The average · volume of acid used to titrate the blank was subtracted 
from the average volume used to titrate the sample. 
Calculationso 
dilution mean daily urine volume 
g N/day = ml HCl X N HCl X 0 0 014 x factor x or mean daily weight of 
feces or food 
Creatinine in Urine 
Creatinine in urine reacted with picrate in an alkaline solution to 
form an intense orange color which was measured spectrophotometrically 
{ 9 2 } o 
water o . 
water o 
Reagents. 
l o Sodium hydroxide j 10% : 10 g of NaOH was diluted to 100 ml with 
2 .  Picric acid, 1% : 1 g of c
6
H3N3o7 was diluted . to 100 ml with 
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3o Alkaline picrate : 100 ml of 10% NaOH was mixed with 100 ml 
of 1% picric acid and diluted to 1 liter with water o 
4 e  Creatinine stock standard , 1 mg/ml : 1 0 6016 g of crystalline 
creatinine zinc chloride was diluted to 1 liter with O o l  N HCl o 
S o Creatinine working standard , O a 05 mg/ml : 5 ml of the stock 
standard was diluted to 100 ml with water o 
Method o One-tenth ml of urine was diluted to 20 ml in a 100 ml 
volumetric flask o Twenty ml of alkaline picrate was added and mixed 
gentlyo After standing for exactly 15 minutes , the contents were diluted 
to volume o Standards were prepared to contain O o OO mg to O u 25 mg in 20 
ml o Absorbances (A) of the standards and samples were determined in 12 x 
100 spectrophotometer tubes with a spectrophotometer at 520 nmo 
Calculations o 
cone of std dilution mg creatinine/ 
24 hours = A of sample x A of std x factor x 
Hydroxyproline in Urine 
daily 
urine vol 
Hydroxyproline (HOP) from acid hydrolyz.ed urine was . oxidized to a 
pyrrole by Chloramine T o The pyrrole ·was condensed with p-dimethylamino­
benzaldehyde (Ehrlich's reagent) to produce a red chromophore which was 
measured spectrophotometrically · (gJ) a 
Reagents o 
l o Sodium carbonate, 5% : 25 g Na2co3 was diluted to 500 ml with 
watero 
2 o · Citrate buffer , O o l M ,  pH 6 :  58 0 8  g of sodium citrate 
(Na3c6H5
o7 ° H2o) was diluted to 2 liter with water and 19 o 2  g citric 
acid (H3C6H5o7 ° H20) was· diluted to 1 liter .with water o Two liters of 
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sodium citrate solution were mixed with 150 ml of the citric acid solu­
tion and the pH of the buffer was adjusted to 6.0 o 
3 . Oxidizing reagent :  1 part Chloramine T and 4 parts buffer 
solution were mixed just prior to use o 
Ao Chloramine T :  3 o 5 g Chloramine T was dissolved, diluted 
to 50 ml with water, and stored in the refrigerator o 
B .  Buffer solution, 'PH 6 :  57 g of sodium acetate 
(CH
3
C00Na O 3H20), 37 o 5 g of sodium citrate 
(Na
3
c
6
H
5
o
7 
° 2H20), 5o5 g of citric acid (H3C6
H
5
o
7 
° H20), 
and 385 ml of isopropyl alcohol were diluted to 1 liter 
with water o 
4o Ehrlich's reagent : 20 g p-dimethylaminobenzaldehyde was dis­
solved in 22 ml of concentrated HCl in a steam .bath after which 128 ml 
of isopropyl . alcohol was added u This reagent was prepared j ust prior 
to use .. 
S o · Hydroxyproline stock standard, 100 µg/ml : 25 mg of L-hydroxy­
proline3 was _diluted to 250 ml with Oo OOl N HCL 
6. · Hydroxyproline working standard, 10 µg/ml : 10 ml of the stock 
standard was diluted to 100 ml with water o The working standard was 
prepared daily o 
Method o Duplicate urine samples to which an equal volume of con­
centrated hydrochloric acid had been added were hydrolyzed for 18 hours 
at 125 ° 0 After cooling, samples were filtered through a sintered glass 
funnel o One ml aliquots of each filtrate were neutralized with 6 ml 
3Nutritional Biochemicals Corporation, Cleveland, Ohioo 
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of 5% sodium carbonate and 3 ml of 0 . 1 M citrate buffer o Two ml of iso-
propyl alcohol and 0 . 5  ml oxidizing reagent were added to l o 5 ml of the 
neutralized filtrate o After 4 minutes at room temperature, the samples 
were chilled in an ice bath . and 5 ml of Ehrlich ' s  reagent .. was added o 
The samples were heated in boiling water for 2 minutes and then cooled 
immediately to room temperature in an ice bath o After standing at room 
temperature for 90 minutes, the absorbance (A) of each sample was deter­
mined on a spectrophotometer at 565 nm o Standards containing O to 10 µg 
of hydroxyproline were prepared under the same conditions o 
Calculations . 
mg HOP/ 
24 hours = A of sample x 
cone of std dilution 
A of std x factor x 
IV . ANALYSIS OF BLOOD CONSTITUENTS 
Hemoglobin in Oxalated Blood 
mean daily 
urine vol 
Hemoglobin was determined by the cyanmethemoglobin method utiliz­
ing the Hycel standard4 and cyanmethemoglobin reagent 4 o Absorbance was 
determined spectrophotometricallyo 
Reagents o 
l o Cyanmethemoglobin reagent: The reagent was obtain, pre-weighed, 
in a sealed vialo Using several rinsings of water , the contents of the 
vial were transferred to a 1 liter volumetric flask and after vigorous 
mixing, the solution was diluted to volumeo 
4Hycel, Inc o , Houston, Texaso 
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2 o Cyanmethemoglobin stan4ard, 80 mg/100 ml : Each vial as 
purchased contained sufficient standard for a curve ranging from O to 
20 g/100 ml . 
3 .  Hemoglobin controlsg Lysed human erythrocytes4 at concentra­
tions comparable to low, normal i and high hemoglobin levels were used 
as _ controls o 
Method . Five ml of the cyanmethemoglobin reagent was pipetted into 
12 x 100 nnn spectrophotometer tubes prior to drawing of the blood o Pi­
pettes calibrat�d to contain O a02 ml were used to deliver duplicate 
samples of . the blood to tubes containing cyanmethemoglobin reagent o 
Thorough mixing was accomplished by inversion . Absorbances (A) were 
determined on a spectrophotometer at 540 nm against a reagent blank set 
at zero absorbance a A standard curve was prepared each time a new re­
agent was used . Instrumentation and technique were checked for each day ' s  
determination by use of the prepared solutions of lysed human erythro­
cytes o · These controls were treated exactly as were the blood sampleso 
Hemoglobin tests were made -within 1 hour after blood was drawn o 
Calculations 
cone of . std dilution 
g hemoglobin/100 ml = A of sample x A of std x factor 
Ascorbic Acid in Plasma 
When deproteinated plasma was added to a dye , the dye was reduced 
by the ascorbic acid in the plasma o This reduction produced a color 
change which was measured on a spectrophotometero The method was a modi­
fication of that by Mindlin and Butler (94)o 
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Reagents. 
1 .  Meta-phosphoric acid, 2 . 5% : 2. 5 g of HP03 was dissolved and 
diluted to 100 ml with water. It _was stored in a brown bottle at 10° 
and a fresh solutio� was prepared every 2 weekso This solution was used 
to dete�ine the proper dye concentration o 
2 .  · Meta-phosphoric acid , 6% : 60 g of HP03 was dissolved and 
dil�ted to 1 liter with water . It was stored in a brown bottle at 10 ° . 
and a fresh solution was prepared every 2 weekso 
3o Sodium acetate, pH 7 :  22 0 65 g of NaC2H5o2 ° 3H2o was dis­
solved in 500 ml water . It was adj usted to pH 7 with 1% acetic acid o 
4. Dy� solution : A few crystals of 2,6-dichloroindophenol were 
dissolved in a small amount of distilled water in a test tubea The solu­
tion was heated in a steam bath to 85 - 90 ° then filtered while hoto 
5 .  Dye-acetate solution : About 5 ml of the dye solution was 
diluted . to 500 ml with water. The proper concentration was adj usted as 
follows : 2 ml of the dye solution was pipetted into a 15 x 150 mm 
calibrated tubeo Two ml of the sodium acetate and 4 ml of 2 o 5% HP03 
were added. The absorbance of the solution was determined at 520 nm 
after setting the instrument to zero absorbance using 8 ml of water as 
a .blank o The absorbance of the trial solution . should be between O a 25 
and O o 35 o The dye solution was altered by the addition of more water if 
the solution had absorbance greater than O a 35, or more dye if it was less 
than O a 25. After the dye solution was altered, the procedure was re­
peated until the absorbance fell within the proper rangeo The dye­
acetate solution was prepared by mixing equal volumes of the diluted dye 
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and the sodium acetate solution o Stored in a brown bottle at 10 °, the 
solution was acceptable for 10 days o 
60  Ascorbic acid standard, 0 0 0125 mg/ml : 50 mg of ascorbic acid3 
was placed in a 500 ml volumetric flask and dissolved o After vigorous 
mixing, 25 ml was pipetted into a 200 ml volumetric flask and diluted 
to volume . The standard was used immediately c 
7.  Blanking solution : 5 ml of 6% HP0
3 
was saturated with ascor­
bic acid a 
Method o Prior to drawing of the blood samples, 7 calibrated 
tubes, 15 x 150 nnn, for the standards and one for each sample were placed 
in a test tube rack wrapped in black cloth � Into each tube was pipetted 
4 ml of the dye-acetat� solution o , In a second test tube rack, to 7 tubes 
for the standards and one for each sample was added 4 ml of 6% meta­
phosphoric acido To tubes for the samples, 2 ml of water was also added o 
For each sample, a test tube fitted with a funnel and Whatman #42 filter 
paper was placed in another black-cloth-wrapped test tube rack to receive 
the plasma-acid mixture e 
Two ml of pl�sma was deproteinated when added to the tubes contain­
ing 4 ml meta-phosphoric acid o The contents were mixed and filtered into 
dry test tubes already set up in the wrapped rack o 
A spectrophotometer was set at 520 nmo To prepare for determination 
of sample absorbances, 4 ml from the zero standard and 4 ml of each plasma­
meta-phosphoric acid filtrate was , pipetted into a calibrated tube contain­
ing the dye-acetate solution o After mixing, each absorbance was determined 
3Nutritional Biochemicals Corporation, Cleveland, Ohio c 
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then a drop of the blanking solution was added and the ·absorbance was 
redetermined. The absorbance of the blanked sample was subtracted from 
that of the sample . 
The ascorbic acid standard was prepared and a standard curve was 
determined immediately after sample absorbance had been obtainedo A 
standard curve was prepared with a range of 0 000125 to 0 000625 mg/mL 
After thorough mixing, 4 ml of each standard was removed, added to the 
dye-acetate solution, and treated in the same manner as were the sampleso 
Absorbances (A) of the . standards were plotted against the ascorbic acid 
concentrations o 
Calculations .. 
ascorbic acid mg/100 ml = 
A of zero A of dilution 
_c_o_n_c __ s_t_d _______ s_am_p_l_e_ x cone of std x factor 
A of zero A of 
cone std std 
Alkaline Phosphatase in Serum 
The activity of alkaline phosphatase in serum was estimated by 
the method of Dryer et al o (90) in which the enzyme was allowed to 
release phosphorus from a glycerophosphate substrate at 37 ° for 1 hour o 
Phosphorus was converted to phosphomolybdic acid which could be reduced 
by N-phenyl-p-phenylenediamine monohydrochloride with the development of 
a blue chromophore proportional to the quantity of phosphorus present o 
Controls were used to obtain a pre-incubation level of phosphorus o 
Reagents o 
l o Trichloroacetic acid (TCA), 30% : 30 g TCA was dissolved in 
100 ml water o 
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2. Trichloroacetic acid (TCA), 10% : 10 g TCA was dissolved in 
100 ml wat_er. 
3. Glycerophosphate substrate, pH 9 . 3 :  0 . 5  g sodium beta­
glycerophosphate and 0 0 424 g of sodium barbital were dissolved 
in 50 ml of warm watero The solution was cooled , transferred to a 100 
ml volumetric flask, and diluted with water o 
4. Ammonium molybdate, 0 0 008 M :  9 . 8  g of (NH4)6Mo7o24 
• 4H
2
o 
was dissolved in 100 ml water o One-tenth ml of concentrated H2 so4 was 
added to aid solubility . Storage was in a polyethylene bottle o 
5 .  N-phenyl-p-phenylenediamine monohydrochloride (PPD) 2, O o5% 
in 1% sodium bisulfite : 50 mg PPD was moistened with 95% ethanol fol­
lowed by about 50 ml water and 1 g NaHso3 before the solution was diluted 
to 100 ml o It was filtered into a brown bottle for storage e 
6 0  Phosphorus stock standard , 1 mg/ml : 438 0 1  mg of KH2P04 was 
dissolved in 100 ml of 10% TCA o 
7 a Phosphorus working standard, 10 µg/ml : 1 ml of the stock 
standard was diluted to 100 ml with 10% TCA o 
Method o Duplicate centrifuge tubes containing 1 0 8  ml of the sub­
strate for each sample were placed in a water bath at 37° for 10 minutes. 
Two-tenth ml of serum was added and the tubes were incubated for 1 hour 
after which the enzyme was inactivated by the addition of O o 5 ml of 30% 
TCA o The mixture was allowed to stand for 10 minutes to assure comp�ete 
precipitation of protein and then centrifuged for 10 minutes at 900 x g o  
· The controls were prepared with the same quantities - of reagents but the 
2Eastman Organic Chemicals, . Rochester, N o Y o  Catalogue #2043 9 
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0 .. 5 ml of 30% TCA was added before the O o 2  ml of serum to assure immediate 
inactivation of the enzymeo 
After centrifugation, 1 ml of the clear supernatant fluid was 
placed in a 12 x 100 mm spectrophotometer tube followed by the addition 
of O o 2  ml of molybdate solution o The contents were mixed � 2 ml of PPD 
was added, and color was developed for 10 minutes before absorbance (A) 
was determined with a spectrophotometer at 770 nm against a reagent blank 
set at zero absorbance o Since each sample was prepared in duplicate, the 
average of .the serum blank was subtracted from the average of the incuba­
ted sample . A standard curve ranging from O to 10 µg phosphorus per ml 
was prepared and utilized in calculating the mg of inorganic phosphorus 
released by the enzyme o 
Calculations o 
mg P/100 ml serum 
( A of A of ) = sample . - blank x 
Total Protein, Albumin, and A/G Ratio in Serum 
cone of std 
A of std X 
dilution 
factor 
Serum proteins were reacted with a biuret reagent to produce a pur­
ple. color , which had an absorbance proportional to the amount of protein 
present o Albumin was determined similarly after removal of the globulin 
by salt fractionation (9S) o 
Reagents o 
L Sodium sul�ite , 28% : After anhydrous Na2so3 was dried at 100
° 
overnight, 280 g was placed in a liter volumetric flask and mixed with . 
about · 800 ml water ,prior to dilution to 1 liter o Two days were generally 
required .for the Na2so3 to go completely into solution o 
ether . 
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2.  Ether-span : About 2 ml of Span-205 was diluted to 200 ml with 
3 .  Biuret reagent : l o 5 g of CuS04 ° 5H2o was , dissolved in 500 ml 
water followed by the ·solution of 6 g potassium sodium tartrate 
(KNaC2H6o6 ° . 4H2o), and 40 g NaOH o After the addition of 1 g of KI the 
reagent was diluted to 1 liter � mixed , and stored in a polyethylene 
bottle . 
4 o Protein standard : Versato1 6 was purchased for use as a stand­
ard o It was hydrated in the vial with 5 ml water according to manufac­
turer ' s  instructions and treated exactly like a serum sample during the · 
analyses . 
Method . For the standard and eac� sample , 12 ml · of the 28% sodium 
sulfite was pipetted into glass-stoppered 15 ml centrifuge tubes o Five­
tenths ml of Versatol . or of serum was added to each . The contents were 
mixed by very gentle inversion 5 times . Duplicate 2 ml aliquots of the 
suspension were pipetted into 12 x 100 mm spectrophotometer tubes and 
identified as total .proteino To the balance of the suspension in the 
centrifuge tube , 2 ml of .ether-span .was added o The tubes were stoppered 
tigh�ly and inverted 15 times in 20 seconds to separate out the globulin o 
After centrifugation at 500 x g for 15 minutes , duplicate 2 ml aliquots 
of · the albumin solution were withdrawn , placed in spectrophotometer tubes , 
and identified as albumin o After the addition of 4 ml biuret , color . . 
5Atlas Che�ical Industries , Inc a , Wilmington , Delaware o  
6Scientific Products Division, Chamblee , Georgia o 
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was developed .in a 37 ° water bath for 15 minutes. The absorbance (A) 
was det�rmined on a spectrophotometer at 550 nm against a biuret blank 
set at zero absorbance 8 
Calculations o 
g total protein/100 ml serum 
A sample total 
= protein x 
cone of std 
A of std 
cone of std 
g albumin/100 ml serum - A sample albumin x A of std 
albumin 
A/G ratio = tot�l protein _ albumin 
Cholesterol in Serum 
Cholesterol in serum was saponified with alcoholic potassium hydrox­
ide o The saponified cholesterol was extracted into petroleum ether, an 
aliquot was evaporated, ·an� the residue was treated with the Lieberman­
Burchard reagent o The absorbance of the green color was proportional to 
the ·quantity of cholesterol present (96) e 
water o 
Reagents o 
l o  Et�anol, 95% 0 
2o Petroleum ether j boiling range j 30 - 60
° 0 
3 o  Potassium hydroxide j 33%: 10 g of KOH was dissolved in 20 ml 
4o · Al�oholic potas�ium hydroxide � Th�s reagent was. prepared just · 
prior to use by placing 6 ml of 33% KOH in a 100 ml volumetric flask and 
diluting to volume with 95% ethanolo 
S o Cholesterol standard, O o 4  mg/ml in ethanol: 20 mg of choles­
terol3 was - dissolved in 50 ml of 95% ethanolo 
3Nutritional Biochemicals Corporation, Clevelan4, Oh�o o 
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6 0 Lieberman-Burchard reagent: 20 volumes of -acetic anhydride 
was chilled to 10 ° 0 One volume of concentrated sulfuric acid was added, 
mixed, and kept cold for 10 minutes. Ten volumes of glacial acetic 
acid was added and the. mixture was warmed to room temperature (25°) 0 
The reagent was used within 1 hour o 
Method . Duplicate 1� ml glass-stoppered centrifuge tubes were 
used for each sample . In each tube O o 25 ml serum was mixed with 2 o 5 ml 
of alcoholic potassium. hydroxide o Triplicate standards were prepared 
containing 2 o 5  ml of the standard and 0. 15 ml of 33% potassium hydroxideo 
Each tube was stoppered and mixed by several inversions. S�ples were 
placed in a 37° water bath for 55 minutes. After cooling to 25 ° , 5 ml of 
petroleum ether and 2 . 5  ml water were added and mixed with tube contents o 
The tu�es were mixed vigorously by inversion for 1 minuteo Separation 
of components was accomplished by centrifugation at 500 x g for 5 minutes o 
Using a pipette equipped with a rubber bulb, 5 ml of the petroleum ether 
layer was removed from each sample and placed in a small dry bottle o 
From the tubes containing the standard, duplic�te 1, 2, and 3 ml aliquots 
(containing 0 . 2, . O o 4, and 0 0 6  mg cholesterol respectively) were removed o 
The petroleum ether aliquot was evaporated to dryness in a 60 ° water 
bath o - A small : dry bottl�, containing no cholesterol, was used for a zero 
standard o 
The instability of the chromophore formed necessitated timed read­
ings after the reagent was added o Thus , prior to color development, the _ 
blan�, ·one set of standards i each pair of samples, and the second set of 
standards were placed in order and 6 ml of the Lieberman-Burchard reagent 
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was added to the bottles at 30 second intervals . The bottles were capped 
and their contents swirled for mixing . Color was developed at 25 ° 0 
Thirty m�nutes after the reagent was added to the blank bottle, its con� 
tents were transferred to a _12 x 100 mm spectrophotometer tube and the 
spectrophotometer _was set to zero absorbance at 620 nm o Similarly, the 
absorbance of each standard and sample was determined in order at 30 
second intervals . 
Calculations 
cone of std dilution 
mg cholesterol/100 ml serum = A of sample - x A of s�d x factor 
Calcium in Serum 
From a deproteinated serum prepared for calcium determination, 
serum calcium was determined by atomic absorption spectrophotometry after 
lanthanum had been added to depress the phosphate (89) e 
Reagents o 
l o  Trichloroacetic acid (TCA), 10% : 10 g of TCA was diluted to 
100 ml with water o . 
2o · Lanthanum oxide, 5% : This reagent was used , as prepared , for 
�he .calcium standards and was diluted for the samples o Final concen­
tration of lanthanum in both standards and samples was 0 0 005 mg/ml o To 
prepare the 5% solution � 5o 9 g of La2o3 was placed in a 100 ml volumetric 
flask o About 50 ml ·of water was added , followed by 25 ml concentrated 
HCl o After solubility was . achieved, the mixture was cooled, diluted to 
volume, filtered, an� used within 1 houro 
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3. Lanthanum oxide , dilution for samples : 20 ml of the 5% 
lanthanum solution was diluted to 100 ml with water . This solution was 
also used within 1 hour o 
4 .  Calcium stock standard � Oo 5 mg/ml : In a 250 ml volumetric 
flask, · 0 . 3121 g of Ca2C03 was moistened with about 50 ml water o One ml 
of concentrated HCl was added to assure solubility befo�e the standard 
was diluted to volume with water. 
5 .  Calcium working standard , 0. 05 mg/ml : 10 ml of the stock 
standard was diluted ,to 100 ml with water . 
Method . To deproteinate the serum , 3 . 6  ml of 10% TCA was mixed 
with 0 . 4  ml serum in 15 ml conical centrifuge tubes� Duplicates for 
each sample were prepared . After standing for 10 minutes , the samples 
were centrifuged at 700 x g for 10 minutes (90) e Two ml of· the de­
proteinated serum solution was removed from each centrifuge tube and 
placed in a 15 x 125 mm acid-rinsed test _ tubeo One ml of diluted 
lanthanum . was added to each sample . Standards were prepared to contain 
Oo OO to 0 . 10 mg calcium and 1 ml of 5% lanthanum was added to each 
standard . All tubes were mixed by a mechanical mixer o The standards 
and samples were aspirated into an acetylene flame of an atomic absorp­
tion spectrophotometer equipped with a calcium-zinc lamp and their 
transmittancies determined at 431 0 2 nm o The standard curve was . plotted 
and the calcium absorbances of the samples were referred to the curve 
to obtain their concentrationso 
Calculations o 
mg Ca/100 ml serum = mg Ca from graph x dilution factor · 
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Phosphorus in Serum 
Deproteinated serum was treated with ammonium molybdate to convert 
inorganic phosphorus to phosphomolybdate which was . reduced by N-phenyl­
p-phenylene.diamine monohydr�chloride o · The absorbances were determined 
spectrophotometrically (90) o 
Reagents . 
1 .  Trichloroacetic acid (TCA), 10%: 10 g TCA was dissolved and 
diluted to 100 ml with water. 
2. Ammonium .�olybdate, 0. 008 M: 9. 8 g (NH4)6
Mo7o24 Q 4H2o was 
dissolved in 100 ml water . One tenth ml of concentrated H2 so4 was added 
to aid solubility • . The solution was stored in a polyethylene container. 
3. N-phenyl-p-phenylenediamine monohydrochloride (PPD)2, Oo 5% ·in 
1% sodium bisulfite: 50 mg PPD was .moistened with 95% ethanol followed 
by about · 50 ml wat_er and 1 g NaHS03 before 
. the solution was diluted to 
100 ml . It was filtered into a brown bottle -for storageo  
4 o Phosphorus stock standard, 1 mg/ml: 438 0 1  mg of KH
2
Po4 was 
diluted to 100 ml with 10% TCAQ 
5 .  Phosphorus working standard, 10 µg/ml: 1 ml of .the stock 
standard . was diluted to 100 ml with 10% TCAo 
Method . Serum was deproteinated by the addition of 0 . 2 ml serum 
to 1 .8  ml of 10% trichloroacetic acid in duplicate 15 ml. conical centri­
fuge tubes . After standing for 10 minutes, samples were centrifuged at 
700 x g for 10 minuteso One ml of the depro�einated serum was removed 
2Eastman Organic Chemicals , Rochester, N o Y o  Catalogue #2043 . 
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from each . . centrifuge tube and delivered to a 12 x 100 mm spectrophoto­
meter tube. Each aliquot was then treated with O o 2 ml · ammonium molybdate 
followed by 2 ml PPD. After standing for 10 minutes to develop the blue 
chromophore ,- the absorbance (A) was determined on a spectrophotometer at 
770 run. A standard curve was prepared to contain O to 10 µg/ml . phos­
phoruso 
Calculations . 
cone of std dilution 
mg P/100 ml = A of sample x A of std x factor 
Carotene and Vitamin A in Serum 
Serum proteins _ were precipitated with alcohol and then carotene 
and vitamin A were extracted into petroleum ether. After the absorbance 
of the carotene was determined, the solvent was evaporated . The inten­
sity of the blue ,chromophore produced by the addition of trifluoroacetic 
acid to the samples was also measured on a spectrophotometer to determine 
vitamin A concentrationo The method was a modification of that used by 
Neeld et al o (97) o 
Reagents o 
1 .  Etha�ol, 95% 0 
2 .. · Pet.roleum ether, boiling range 37 - 44 ° o 
3 o Chloroform o 
4 o Acetic anhydride o 
S o Trifluoroacetic acid-Chloroform chromagen : The chromagen was 
prepared just prior to use by mixing 1 volume of trifluoroacetic acid 
with 2 volumes of . chloroform o 
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6. Carotene sta�dard, 5 µg/ml: 50 mg beta-�arotene7 was dissolved 
in 5 ml chloroform and diluted to 100 ml with petroleum ether. The con­
centration was 0. 5 mg/ml. One ml was further diluted with petroleum ether 
to 100 ml for use in the preparation of - the standard curve o Carotene is 
stable in petroleum .ether for just a few hours . 
7. Vitamin A standard , 3 . 75 µg/ml: 50 mg of Vitamin A acetate in . 
cottonseed oils was dissolved in 5 ml chloroform and diluted to 50 ml 
with petroleum ether. For the final concentration, 12 . 5  ml was diluted 
to 100 ml with petroleum ether . The vitamin A standard was stable under 
refrigeration for 2 days . 
Method. Samples were prepared in glass-stoppered centrifuge tubes 
by mixing 2 ml serum, 2 ml ethanol, and 4 ml petroleum ether followed by 
vigorous agitation for 2 minutes . Samples were centrifuged for 3 min­
utes at 500 x g. Three ml aliquots were removed and placed in 12 x 100 
mm spectrophotometer tubes. Absorbances of samples and . carotene stand­
ards ranging in concentration from O o OO to 2 . 50 µg/ml were determined 
on a spectrophotometer at 450 nm using petroleum ether as a blank o Then 
samples, carotene sta�dards, and vitamin A standards ranging from O o 25 to 
1 . 25 µg/ml were evaporated to dryness in a 60 ° water bath . Residues · 
were dissolved in 0 . 3  ml chloroform followed by the addition of Oo 3 ml 
acetic ·anhydride . Three ml of trifluoroacetic acid-chloroform chromagen 
was added and 5 seconds later the absorbances (A) were determined at 620 
nm. A carotene correction factor obtained from the carotene standards 
treated as vitamin A was calculated to correct for the contribution of 
carotene to the vitamin A chromophore o 
7Hoffmann-LaRoche Company, Nutley, N o J o 
Bunited States Pharmacopeial Convention, Inc. 34 o·4 mg all-trans 
retinyl acetate equivalent to 30 . 0  mg · retinol · per gram in cottonseed oil . 
Calculations o 
µg carotene/100 ml serum = A of sample450 x C 
Under conditions of this laboratory : 
cone of std dilution 
C • A of std x factor • 1234 
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µg vitamin A/100 ml seru� • ( s�mple A
620 
Under conditions of this laboratory : 
carotene A620) x C 
cone of vitamin A std 
C • A of vitam.in A std x 
dilu�ion 
factor • 507 , and 
carotene A
620 
• carotene A
450 
x carotene correction factor 
Where : 
carotene correction factor • 
µg carotene in std 
carotene A620 in std 
V. STATISTICAL ANALYSES 
Correlations between Measurements 
• 
Simple correlation coefficients · were calculated between bone den­
sity and age p weight , and height at the initial test period o 
Description of Canonical Correlation and Factor Analysis 
Both canonical correlation and factor analysis are methods of multi­
variate analyaea n Canonical correlation coefficients measure the simul­
taneous 'relation1hip between 2 groups of variables �here variable• within 
eac� group are correlated o Canonical variable• , defined a1 the sums of . 
product, of each measurement within each group and its normalized char­
acteri1tic vector , are produced by a canonical correlation analy1i1 0 
The first canonical correlation represents the maximu� correlation 
between linear combinations of measurements withi� each group a The Chi� 
Square te1t for 1ignificance , i1 utilized with canonical correlationa o 
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By factor analysis , a large number of cor�elated variables are 
reduced to a few uncorrelated vari�bles for the purpose of . identifying 
those measurements which are most influential in SUIIID:1arizing variability 
and covariability of the .measurements employed (98) o 
Multivariate Analyses 
Canonical correlation analyses were performed on physical and 
dietary , physical and blood , and dietary and blood variables est imated 
in the initial pha�e of the study o All measurements for the 17 women 
who were receiving vitamin supplements were excluded from the canonical 
correlations . In the first analysis the physical measurements of bone 
density , age, weight , and height were related to dietary energy , protein , 
fat , calcium,  phosphorus , iron , vitamin A, and ascorbic acid . The second 
analysis related the physical measurements to seru� levels of ascorbic 
acid , ·hemoglobin , tot•l protein , albumin , the A/G ratio , cholesterol , 
vitamin A, calcium, pho1phoru1 1 an� alkaline ph�sphatase o A third 
analysis i�dicated the relationships between the dietary measurements 
and serum levels of selected blood const ituent s o  The Stat istical Analysis 
System (a computer software package) developed by Barr and Goodnight (99)  
was used for calculating the canonical correlations o 
Tests for Significance of Differences o 
With the rationale that each individual was her best control , a 
difference was calculated for each individual ' s  measurements , for example , 
final test value minus initial test value o The paired t-test was used to 
evaluate whether the mean difference of a given group was . signif icantly 
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different from zero o To test whether the mean differences between the 
final and initial tests of the 4 groups were significantly different 
from each other, a least squares analysis of variance and Duncan's 
New Multiple-Range test were employed (lOO)o 
CHAPTER IV 
RESULTS 
I o  NUTRITIONAL STATUS 
Physical Measurements 
The mean bone density index of the 76 aged women was O o 819 ± 0 0 022 
g equivalents of alloy per cc of bone (Table 4) � The mean weight of the 
women was 65 o 4  ± 2 o l kg and the mean height was 156 03  ± ·l o O cm o The mean 
age was 68 0 0  ± ·Oo 9 yea�s o 
.Nutrient Intake 
Nutrient intakes from food of the women were consistent with those 
recommended by the National Research Council (7) o Mean intak�s for the 
8 nutrients evaluated are shown in Table S o  Energy intake per day was 
1519 ± 42 kcal . Approximately 15 and 36% of the .kcal were obtained from 
protein and fat respectivelyo The meari intake of protein was 58 ± 2 g 
and that of fat was 62 � 2 g.  The mean calcium intake . was 797 ± 27 mg ; 
th�t of phosphorus was 1001 ± 29 mg. The mean intake of iron was 8 0 6 ± 
O o 2 mg/day o · Vitamin A and ascorbic acid consumed from the .diet. by the 59 
women who were not -receiving vitamin · suppl�ents showed daily means of 
5831 ± 665 IU and 35 ± 2 mg� respectively o The 17 women for whom a 
vitamin s�pplement h�d been prescribed were receiving 25 ,000 IU and 200 
mg of vitamin A and ascorbic acid respectively � from that sourceo 
Blood Levels of Selected Constituents 
Mean levels of blood constituents are shown.in Table 6 0  Vitamin 
lev�ls are exclusive of values for 17 persons whose diets were supplemented 
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TABLE 4 
PHYSICAL MEASUREMENTS OF ELDERLY WOMEN AT THE INITIAL 
TEST PERIOD (n=76 ) 
Measurement Mean 
Age (years) 68.0 
Height (cm) 156.3 
Weight (kg) 65.4 
Bone Density 1 Index 0.819 
1 
Gram equivalents of alloy per cc of bone. 
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± SE 
± 0.9 
± 1.-0 
± 2.1 
± 0.022 
TABLE 5 
DAILY NUTRIENT INTAKE OF ELDERLY WOMEN AT THE INITIAL 
TEST PERIOD (n=7 6 )  
Nutrient RDA
1 Mean 2 
Energy (kcal) 1700 1519 
Protein (g) 55 58 
Fat (g) 62 
Calcium (mg} 800 797 
Phosphorus (mg) 800 1001 
Iron (mg) 10 8. 6 
Vitamin A (IU) 5000 583 1
3 
Ascorbic Acid (mg) 55 35 .  2
3 
1 
Recommended Dietary Allowance (7) . 
2 Mean of 4 or 7 days . 
\tean is exclusive of 17 women who were receiving vitamin 
supplements . 
50 
± -SE 
± 42 
± 2 
± 2 
± 27 
± 29 
± 0. 2 
± 665 
± 1 . 8  
... 
T,A.BLE 6 
BLOOD LEVELS OF SELECTED CONSTITUENTS OF ELDERLY WOMEN 
AT THE INITIAL TEST PERIOD (n= 76 ) 
Acceptable 
Constituent Valuesl Mean 
Blood Hemoglobin (g/100 ml) 12. 0  - 16. 0 13. 93 
Plasma Ascorbic Acid (mg/100 ml) 0.3 - 1. 4 0. 34
2 
Serum Total Protein (g/100 ml ) 6. 0 - 8. 0 6. 77 
Serum Albumin (g/100 ml ) 4. 0 - 5. 5 3. 67 
Serum A/G Ratio (g/100 ml) 1. 8 - 2.5  1. 22 
Serum Cholesterol (mg/100 ml) 120 - 260 2 2 2. 0  
Serum Calcium (mg/100 ml) 9. 0 - 11. 0 9. 60 
Serum Phosphorus (mg/100 ml) 3. 0 - .4. 0 3. 35 
Serum Vitamin A (µg/100 ml) 25 - 90 50. 36 2 
Serum Alkaline Phospha�ase (mg/100 ml ) 3 1. 92 
1
Normal laboratory values of clinical importance (101). 
51 
± SE 
± 0. 11 
± 0. 03 
± 0. 05 
± 0. 03 
± 0. 03 
± 4.·4 
± 0. 08 
± 0. 09 
± 2. 06 
± 0. 08 
2
Mean is exclusive of 17 women who were receiving vitamin supplement • 
strate 
. 3 .' Inorganic phosphorus 
in 1 hour at 37°. 
liberated from glycerophosphate sub-
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with vitamins prior to their participation in . the study. The mean level 
of serum ascorbic acid for women who were not receiving vitamin supple� 
ments was - 0 . 34 ± 0 . 03 mg/100 ml v A mean serum level of 50 . 36 ± 2. 06 µg 
vitamin A/100 ml was observed for the same women . When values for the 
17 supplemented women were included the means of - plasma ascorbic acid 
an4 serum vitamin A were elevated by 50 and 2% respectively . With a 
mean of 13. 93 ± 0. 11 g/100 ml, hemoglobin was within the range of normal 
for adults as was . cholesterol with a mean of 222 . 0  ± 4 . 4 mg/100 ml (101) . 
Serum total protein h�d a mean of 6 . 77 ± 0 . 42 g/100 ml; the mean albumin 
content was 3 . 67 .± 0 . 03 g/100 ml. The albumin to globulin (A/G) ratio was 
1 ; 22 ± 0 . 03. Serum levels of calcium and phosphorus had means of 9 . 60 ± 
0 . 08 and 3 . 35 ± 0 . 09 mg/100 ml respectively. The activity of the enzyme, 
alkaline phosphatase, was estimated to be l o 92 ± 0 . 08 mg/100 ml o 
Interrelations of Dietary Intake, Blood Levels of Selected Constituents, 
and Physical Measurements · 
A significant negative corr�lation betwee� age . and bone density 
(r = 0 . 4 ,  P < 0 . 01) indicated that the bone density decreased. with 
advancing age . Significant positive correlations were observed between 
bone density and height (r = O o5 � P < Oo OOl) and weight (r = O o 5 �  
P < 0 . 001) as presented in Table 7 .  
Canonical correlation between nutrient intakes and physical meas­
urements . of the subjects who were not receiving vitamin supplements 
(Table 8) revealed that increased age of the women was accompanied by 
decreased body weight and a reduction in consumption of nutrients such as 
protein� calcium � phosphorus i and ascorbic acid (r = 0 . 7 �  .p < 0 . 0006) 0 
\ 
TABLE 7 
CORRELATION OF BONE -DENSITY1 WITH PHYSICAL MEASUREMENTS 
AT THE INITIAL TEST PERIOD {n= 76) 
Relationship Tested r value P value 
Age -0.3655 <0.01 
Height 0.4621 <0.001 
Weight 0.5141 <0. 001 
1Gram equivalents of alloy per cc of bone. 
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TABLE 8 
CANONICAL VARIABLE CORRELATIONS OF THE RELATIONSHIP OF PHYSICAL 
AND DIETARY MEASUREMENTS AT THE INITIAL 
TEST PERIOD (n=59) 
Canonical correlations 
Chi-square 
Degrees of freedom 
Probability chf-square 
Correlation coefficients of the 
canonical variable with each 
variable of the group 
Physical 
Bone density 
Age 
Height 
Weight 
Dietary 
Energy 
Protein 
Fat 
Calcium 
Phosphorus 
Iron 
Vitamin A 
Ascorbic Acid 
Cano.nical Variables 1 
1 2 
0 . 7 
32 
0 . 0006 
-0 . 4 7 
0 . 91 
-0 . 43 
-0. 92 
-0 . 36 
-0 . 55 
-0 . 35 
-0 . 41 
-o . so 
-0. 19 
-0 . 25 
-0 . 57 
0 . 6  
21 
0 . 06 
0 . 62 
-0 . 18 
0 . 30 
-0 . 13 
-0 . 04 
-0 . 04 
-0 . 12 
-0 . 04 
-0 . 06 
0 . 11 
0 . 54 
0 . 44 
1 
Canonical variables are the sums of the products of the 
criterion variables and the normalized characteristic vecto.r . 
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An .addition�l ·significant corFelation (r = 0. 6, P < Oo07) independent of 
the ·first canonical variable indicated a relationship between decreases 
in : bone density and height and reduction in intakes of vitamin A and 
ascorbic acid. The canonical correlation presented in Table 9 re-
vealed a relationship (r = O o 7 9 P < 0 0007) between . weight and serum 
levels of ascorbic · acid j hemoglobin , alkaline phosphatase i and phos-
phorus; however a subsequent factor analysis showed that at best only 
20% of the correlative.effects could be attributed to levels of serum 
constituents. Another significant canonical correlation (r = 0.8 ,  P < O o05 )  
was shown between nutrient. intakes and serum levels of selected nutrients 
(Table 10) attributable primarily to a relationship of dietary vitamin A 
(r = 0 . 9  in the dietary canonical variable) to serum ascorbic acid 
(r = 0. 9 in the blood variable)o 
Metabolic Balances and Urinary Constituents 
Utilization of nitrogen , calcium , and · phosphorus by the 16 women 
who participated in the metabolic studies is shown in Table 11. A mean 
apparent nitrogen balance of 2 o 30 ·g per day was estimated in the initial 
phase of this study @ The nitrogen which was consumed in the diet was 
analyzed to be 9 o 00 .g daily � Of that intake , me�n values of 6 0 04 and 
O o 67 were recovered from the urinary and fecal excretions respectivelyo  
Nitrogen intake was positively correlated with nitrogen . balance at r = 0. 7, 
P < 0 .001. A negative apparent calcium balance of -52 mg per day was 
registered and fecal calcium accounted for more than three-fourths of 
the calcium consumed ; however � a significant positive correlation (r = 0. 6 , 
P < O o Ol) between intake and balance of calcium was observed . A positive 
TABLE 9 
CANONICAL VARIABLE CORRELATlONS OF THE RELATIONSHIP OF PHYSICAL 
AND BLOOD MEASUREMENTS AT THE INITIAL 
Canonical correlation 
Chi-square 
Degrees of freedom 
Probability chi-square 
TEST PERIOD (n=59 ) 
Correlation coefficients of the 
canonical variable with each 
variable of the group 
Physical 
Bone density 
Age 
Height 
Weight 
Blood 
Ascorbic Acid 
Hemoglobin 
Total Protein 
Albumin 
A/G Ratio 
Cholesterol 
Calcium 
Phosphorus 
Vitamin A 
Alkaline Phosphatase 
1 
Canonical Variable 
1 
0 . 7 
40 
0 . 001 
0 . 28 
-0 . 08 
-0 . 12 
0 . 67  
-0 . 39 
0 . 56 
0 . 21 
0 . 06 
-0 . 15 
-0 . 14 
-0 . 08 
-0 . 56 
0 . 09 
0 . 44 
1canonical variables are the sums of the products of the 
criterion variables and the normalized characteristic vector . 
56 
TABLE 10 
CANONICAL VARIABLE CORRELATIONS OF THE RELATIONSHIP OF DIETARY 
AND BLOOD MEASUREMENTS AT THE INITIAL 
Canonical correlation 
. Chi-square 
Degrees of freedom 
Probability chi-square 
TEST PERIOD (n=59 ) 
Correlation coefficients of the 
canonical variable with each 
variable of the group 
Dietary 
Energy 
Protein 
Fat 
Calcium 
Phosphorus 
Iron 
Vitamin A 
Ascorbic Acid 
Blood 
Ascorbic Acid 
Hemoglobin 
Total Protein 
Albumin 
A/G Ratio 
Cholesterol 
Calcium 
Phospho.rus 
Vitamin A 
Alkaline Phosphatase 
Canonical Variable 1 
1 .  
0 . 8 
80 
0 . 05 
0 . 01 
0 . 08 
0 . 11 
-0. 17 
-0 . 04 
0 . 22 
0 . 87 
0 . 29 
0 . 92 
0 . 03 
-0 . 07 
0 . 18 
0 . 17 
-0 . 07 
-0 . 10 
-0 . 19 
-0 . 03 
-0 . 09 
1canonical variables are the sums of the products of the 
criterion variables and the normalized characteristic vector . 
57 
58 
TABLE 11 
METABOLIC MEASUREMENTS AT THE INITIAL TEST PERIOD FOR PARTICIPANTS 
IN THE BALANCE STUDIES (n•l6) 
Constituent 
Nitrogen (g/day) 
Intake 
Urinary 
Fecal 
Balance 
Calcium (mg/day) 
Intake 
Urinary 
Fecal 
Balance 
Phosphorus (mg/day) 
Intake 
Urinary · 
Fecal 
Balance 
Hydroxyproline , Urinary 
(µg/24 hours) 
Creatinine , Urinary 
(mg/24 hours) 
�ean of 7 days. 
Mean1 + SE 
9.00 ± 0.66 
6.03 ± Q.47 
Q.67 ± o . os 
2.3 0 ± Q.27 
770 ± 69 
139 ± 27 
683 ± 76 
-52 ± 85 
1038 ± 69 
417 ± 28 
363 ± 31 
258 ± 52 
24.06 ± 1 .  72 
607 ± 46 
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apparent phosphorus balance of 258 mg per day was obtained. A highly 
significant correlation between intake and balance of phosphorus was 
observed (P < O. OOl) o Urinary creatinine was found to have a mean daily 
value of 607 ± 47 mg o The mean daily urinary excretion of hydroxyproline 
was 24 0 06 ± l o 72 µg o The interrelations of the metabolic balances with 
bone density and hydroxyproline excretion of these subjects have been 
described and discussed in detail in a thesis by MacDuff (102) e 
II . EFFECTS OF DIETARY SUPPLEMENTATION 
Although groups were matched for bone density, age� and weight at 
the onset of supplementation � re-evaluation of the initial bone densities 
after deletion of values for those who did not complete the study showed 
that withdrawals.from the study had impaired the initial matching o To 
compensate for the unmatched groups, final minus intermediate bone den­
sity measurements were regressed on initial measurements and this test 
of homogeniety indicated that changes in bone density in response to 
supplements was not affected by the levels of the initial measurements o 
Response to dietary supplements was therefore evaluated by a least 
squares analysis of variance of the difference between the initial and 
final measurements e Changes in each group between the initial and final 
measurements were tested by the paired t-testo Significant alterations 
in . nutrient .intake 9 blood constituents, and physical measurements between 
groups were subsequently determined using the Duncan ' s  New Multiple-Range 
Test (lOO)o 
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Bone Density and Physical Measurements 
Supplementation with sodium fluoride (Group 3) resulted in a 
significant (P < O a Ol) increase between the i�itial and final bone den­
sity indices for that group (Table 12) u There were no significant 
changes in bone density measurements of the other 3 groups o The multi­
ple�range - test showed that the increased bone density of Group 3 was 
significantly greater than that of Groups 1 and 2 (Table 13) ; the · same 
testing indicated that fluoride alone was more effective in increasing 
bone mass than was fluoride given in combination with vitamins and cal­
cium phosphate . There had been no significant alteration of bone density 
at the intermediate test period . No significant correlations were found 
between the changes . in bone density and changes in nutrient intake or 
levels of blood cons�ituents evaluated during t�e experimental period. 
Neither height - nor weight changed significantly during the course of . 
this study . 
Nutrient Intake 
A decrease in calcium intake from food between the initial and 
final test periods registered for Group 3 was significant (P < 0 .05) 
as indicated in Table 14 0 Calcium and phosphorus in�akes increased � 
as was - expected , in Groups 2 and 4 by the addition of calcium phosphate 
supplements to the diets (P < O . OOl) o The multiple-range test as shown 
in Table 15 indicated that p although the increased intakes of : Groups 2 
a�d 4 were significantly greater than those of the other groups , the 
decreased intake of calcium by Group 3 was not significantly different 
from that of Group la 
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TABLE 12 
PHYSICAL MEASUREMENTS Ai THE INIT�AL AND FINAL TEST PERIODS BY GROUP 
1 
Bone Density Index 
Initial 
Intermediate 
Final 
3 
Difference 
Height (cm) 
It1itial 
Final 
Difference 
Weight (kg) 
Initial 
Final 
Difference 
1 
None 
(n=l7) 
a . sol 
±0. 044 
Q . 813 
±0. 044 
0. 823 
±0. 040 
Q . 016 
153 . 6  
±1. 4 
153 . 9  
±1. 4 
Q . 3 
65 . 7  
±4 . 5  
68 . 3  
±4 . 8  
2 . 6  
Group. and Supplement 
2 3 
Ca.., P 
{n=l3) 
Q . 824 
±0 . 041 
Q . 841 
±0. 044 
0 . 842 
±0. 046 
0 . 019 
1.54 . 4 
±1. 2 
153 . 5  
±1. 4 
-o. 9 
59 . 1  
±3 . 5  
58 . 6  
±4 . 1  
-o . 4 . 
' F  
{n=l8) 
Q . 820 
±0 . 056 
Q . 832 
±0. 046 
Q . 906 
±0 . 053 
o .  0864 
158 . 5 
±1 . 8  
157 . 6  
±1 . 9  
-1 . 0  
67 . 5  
±6 . 1  
66 . 4 
±6 . 0  
-1 . 1  
1 Gram equivalents of alloy per cc of bone . 
�ean ± SE . 
· 4  
F , Ca , P ,  
Vitamins 
(n=l2) 
0 . 808 
±0 . 053 
0 . 822 
±0. 048 
o .  842 
±0 . 056 
0 . 033 
154 . 5  
±2 . 6  
153 . 5  
±2 . 4  
-L O 
64 . 1  
±3 . 4 
61. 8 
±3 . 0  
-2 . 4 
\rean of individual differences; final minus initial measurement . 
4 
Significantly different from zero by paired t-test at P<O.  01 .· 
TABLE 13 
DIFFERENCES IN PHYSICAL MEASUREMENTS AND THEIR 
SIGNIFICANCE AMONG GROUPsl, 2, 3  
Grou;e and Su;e;element 
1 2 3 
None Ca, P  F 
(n=l7} (n=13l (n= l8l 
Bone Density Index 4 0.016b 0 . 019b 0 . 086a 
±0 . 020 ±0 . 024 ±0 . 020 
Height (cm) 0. 28 -0. 93 -0 . 96 
±0 . 16 ±0 . 71 ±0 . 45 
Weight (kg) 2.65 -0. 45 -1 . 11 
±1 . 88 ±1 . 52 ±1 . 33 
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4 
F , Ca , P ,  
Vitamins 
(n=l2l 
0 . 033
ab 
±0 . 024 
-0.96 
±0 . 53 
-2 . 37 
±1.84 
1 
Difference equals final minus initial measurement by subj ect. 
2 
Values expressed as mean ± SE . 
3 
Means in a row without a common superscript are significantly 
different from each other at P<0.05 . 
4 Gram equivalents of .alloy per cc of bone . 
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TABLE 14 
NUTRIENT INTAKES AT THE INITIAL AND FINAL TEST PERIODS BY GROUP 
Grou;e and Su;e;element .. 
1 2 3 4 
F,Ca,P, 
None Ca,P F Vitamins 
(n=17) (n=l3) (n= 18) (n=12) 
Energy (kcal) 
1462
1 
Initial 1527 1677 1563 
±119 ±74 ±84 ±58 
Final 1428 1608 1562 1486 
±71 ±95 ±73 ±80 
Difference 
2 -34 81 -115 -76 
Protein (g) 
Initial 57 57 63 62 
±5 ±2 ±4 ±2 
Final 54 56 62 59 
±4 ±3 ±4 ±4 
Difference -3 -2 -1 �3 
Fat (g) 
Initial 58 65 67 67 
±4 ±3 ±3 ±2 
Final 58 67 66 66 
±3 .;!:4 ±4 ±4 
Difference 0 2 -1 -1 
Calcium (mg) 
Initial 713 819 874 851 
±50 ±52 ±59 ±43 
Final 712 1241 761 1207 
±34 ±43 ±62 ±51 
Difference 0 422
3 4 -113· 356
3 
Phosphorus (mg) 
Initial 
Final 
Difference 
Iron (mg) 
Initial 
Final 
Difference 
Vitamin A (IU) 
Initial 
Final 
Difference 
Ascorbic Acid (mg) 
Initial 
Final 
Difference 
�ean ± SE. 
TABLE 14 (continued) 
None 
(n=17) 
947 
±68 
951 
±48 
4 
8. 5 
±0. 8 
8.7 
±0. 7 
0 . 2  
5045 
±544 
7844 
±1593 
2799 
32 . 3  
±2.8 
38.5 
±5 . 2  
6.2 
Group and Supplement 
2 3 
Ca , P  
(n=l3 ) 
1018 
±47 
1 367 
±53 
3483 
8 . 8  
±0. 5 
8 . 8  
±0. 6 
0 
29795 
±469 
30620 
±595 
565 
231. 9 
±3.0 
241 . 5 
± 3.9 
9 . 83 
F 
(n=l8) 
1090 
±64 
1048 
±65 
-42 
9. 3 
±0 . 6  
9.5 . 
±0. 5 
0 . 2  
6215 
±1436 
5712 
±1172 
-504 
38 . 4  
±4.2 
36 . 4  
±3 . 2  
-1 . 9 
64 
4 
F , Ca , P  
Vitamins 
(n=l2) 
1054 
± 38 
1349 
±60 
2953 
9 . 1 
±0 . 4  
9.1 
±0 . 6  
0 
5251 
±482 
31473 
±1043 
262225 
37.5 
±2. 5 
236 . 0  
±4 . 7  
198 . 55 
2Mean of individual differences : final minus initial measurement. 
3significantly different from zero by paired t-test at P<0 . 01 .  
4significantly different from zero by paired t-test at P<0.05 . 
5significantly different from zero by paired t-test at P<0.001. 
TABLE 15 
DIFFERENCES IN NUTRIENT INTAKES AND THEIR 
SIGNIFICANCE AMONG GROUPsl ; 2, 3 
Grou;e and Su;e;element 
1 2 3 ·  
None Ca,P F 
(n=l 7 }  (n=l3 } (n= l8}  
Nutrient 
Energy (kcal) -34.11 81.38 -114.79 
±93.48 ±106.98 ±98.82 
Protein (g) -2.63 -1.56 -0.72 
± 3.48 ±3.98 ± 3. 38 
Fat (g) 0. 36 1.51 -1.40 
±3.96 ±4.53 ±3.84 
Calcium (mg) -0.06
b 
422.46
a 
. -11 2. 62
b 
±49.40 ±56.53 ±47.99 
Phosphorus (mg) 4.24b 348.46
a -42.17
b 
±58.98 ±67.50 ±57.30 
Iron (mg) 0.19 0.04 0.17 
±0.63 ±0.72 ±0.61 
Vitamin A (IU) 
-- -·· 
b
· -
2799 565b -504
b 
±1369 ±1630 ±1330 
Ascorbic Acid (mg) 6.18
b 
9.88
b -1. 92
b 
±4.03 ±4.80 ± 3 � 91 
1 
Difference equals final minus initial measurement by 
2 Values expressed as mean ± -SE. 
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4 
F, Ca,P 
Vitamins 
(n=l 2 } 
-76.08 
±111. 27 
-3.42 
±4.14 
-1. 2 2  
±4.71 
355.66
a 
±58.80 
295.24
a 
±70.21 
-0.02 
±0. 75 
26221a 
±1630 
198.48
a 
±4.80 
subject. 
3
Means in a row without a common superscript are significantly 
different from each other at P< O.QS. 
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Increases in the mean intakes of vitamin A and ascorbic acid in 
subjects in Group 4 were significant (P < Oo OOl) as a result of .the 
vitamin supplement which each member of this group received. Since 
Group 2 was receiving the vitamin supplement prior to the study and that 
supplement was maintained throughout the study 5 there were relatively 
small changes in intakes of vitamin A and ascorbic acid by that group o 
Dietary intakes of energy, protein, fat, anq iron were not signif­
icantly altered during the course of this st�dy in any of the groups o . 
Blood Constituents 
Plasma levels of ascorbic acid were increased in Groups 1, 3, .·and 
4 between the initial a�d final test periods (Table 16) ; the paired 
t-test showed that the increases w�re significanto The increase in 
Group 1 was significant at P < 0. 01 while that of Group 3 was signif­
icant at P < Oo 05, and that of Group 4 was significant . at P < O o OOl. 
Those in Group 2 who were receiving vitamin supplements at the initial 
'test perio.d had a plasma . level of ascorbic acid at L l� ± O o .17 mg/100 ml 
and it did not change appreciably during the study o The multiple range 
test revealed that the increase in plasma lev�l of .Group 4 was signif- . 
icantly different from those in the other groupso Group 2 showed a 
slight decrease in plasma ascorbic acid and the change was. significantly 
different from those of Groups 1 ·and 3 (Table 17) o 
Group 2 showed a significant increase in .serum tot�l protein 
(P < O o Ol) and albumin (P < Oo OS)without significant alteration of · the 
A/G Ratio (Table 16) o Serum albumin increased significantly in Group 1 
(P < Oo OS) and Group 3' (P < O o Ol) o The elevation of · serum albumin al­
ter�d the A/G Ratio significantly (P < 0.01) in Group 3 and the ratio 
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TABLE 16 
BLOOD VALUES AT THE INITIAL AND FINAL TEST PERIODS BY GROUP 
GrouE and SuEElement 
1 2 3 4 
F,Ca,P 
None Ca , P  F Vitamins 
(n=17) (n=l3) (n=18) (n=l2) 
Plasma Ascorbic Acid (mg/100 mll 
Initial 0.29 1.15 0. 38 o. 29 
±0.04 ±0.17 ±0.08 ±0.03 
Final 0.61 1.10 o.73 1.34 
±0.08 ±0.14 ±0.11 ±0.04 
Difference 2 0. 323 -0.08 0. 35
4 1.05
5 
Blood Hemoglobin (g/100 ml) 
Initial 14.10 13.20 14.03 14.15 
±0.19 ±0. 31 ±0.24 ±0. 35 
Final 14.26 13. 60 14.59 14.36 
±0.22 ±0.51 ±0.27 ±0.39 
Difference 0.16 0.40 0.56 0.21 
Serum Total Protein (g/100 ml) 
Initial 6.79 6.74 6.78 6.98 
±0.11 ±0.11 ±0.09 ±0.10 
Final 6.93 7.06 6.85 6.80 
±0.10 ±0.12 ±0.10 ±0.08 
Difference 0.14 Q.323 0.07 -0.16 
Serum Albumin (g/100 ml) 
Initial 3.69 3. 58 3.65 3.74 
±0.06 ±0.07 ±0.07 ±0.06 
Final 3.85 3.78 3.90 3.88 
±0.04 ±0.08 ±0.06 ±0.08 
Difference 0.16
4 
0.19
4 0.26
3 0.14 
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TABLE 16 (continued) 
GrouE and SuEElement 
1 2 3 4 
F,Ca,P 
None Ca,P F Vitamins 
(n=l7) (n= l3) (n=l8) (n=l2) 
Serum A/G Ratio (g/100 ml) 
Initial 1.21 1.21 1.19 1.18 
±0.05 �0 .08 ±0.06 ±0.06 
Final 1. 28 1.18 1. 36 1.33 
±0.05 ±0.07 ±0.06 ±0.08 
Difference 0.06 -0.02 0.16
3 
0.15
4 
Serum Cholesterol (mg/100 ml) 
Initial 214.1 234.9 221.6 224.6 
±9.6 ±11. 7 ±10.5 ±8.2 
Final 217.9 246.8 219.0 228.2 
±13.3 ±15.4 ±10.7 ±12.1 
Difference 3.9 11.9 -2.6 3.7 
Serum Calcium (mg/100 ml) 
Initial 9. 49 9.83 9.68 10.19 
±0.13 ±0.21 ±0.10 ±0.16 
Final 9.51 9.75 9.60 9.38 
±0.09 ±0.14 ±0.11 ±0.1 3 
Difference 0.01 -0.08 -o . 09 -0 .815 
Serum Phosphorus (mg/100 ml) 
Initial 3.25 3.75 3.34 3.49 
±0.11 ±0. 44 ±0.09 ±0.10 
Final 3.13 3.08 3.03 2.86 
±0.09 ±0.15 ±0.09 ±0.11 
Difference -0.12 -0.67 -0.31 
4 
-0.63
3 
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TABLE 16 (continued) 
Grou;e and Su;e;element 
1 2 3 4 
F , Ca , P ,  
None Ca , P  F Vitamins 
(n=l7 ) (n=l3 ) (n=l8 ) (n=l2) 
Serum Vitamin A· (µg/100 ml) 
Initial 51 . 90 52 . 98 46 . 47 51 . 82 
±4. 69  ±4. 68 ± 3 . 5 5  ±3 . 56 
Final 51 . 00 60 . 53 49 . 5 9 63 . 58 
±2 . 28 ±7 . 92 ±2 . 74 ±3 . 32 
Difference -0. 93 7 . 78 3 . 12 11 . 75
3 
Serum Alkaline Phosphatase (mg/100 ml) 
6 
Initial 1 .  7 9  l .  7 4  2 . 04 2 . 18 
±0 . 14 ±0. 16 ±0 . 19 ±0 . 31 
Final 2 . 48 2 . 88 3 . 55 3 . 33 
±0. 2 3 ±0. 3 9 ±0 . 24 ±0 . 38 
Difference 0 . 10
5 1. 143 1 . 51
5 
l . 14� 
�ean ± SE. 
2
Mean of individual differences : final minus initial measurement . 
3significantly different from zero by paired t-test at P<O . 01 . 
4 
different from by paired P<0 . 05 . Significantly zero t-test at 
5 
Significantly different from zero by paired t-test at P<O . 001 . 
6 
Inorganic phosphorus liberated from glycerophosphate substrate 
in 1 hour at 37 ° � 
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TABLE 17 
DIFFERENCES IN BLOOD LEVELS OF SELECTED CONSTITUENTS AND 
THEIR SIGNIFICANCE AMONG GROUPsl, 2, 3 
Constituent 
Plasma Ascorbic 
Acid (mg/100 ml ) 
Blood Hemoglobin 
(g/100 ml) 
Serum Total Pro­
tein (g/100 ml) 
Serum Albumin 
(g/100 ml) 
Serum A/G Ratio 
(g/100 ml ) 
Serum Cholesterol 
(mg/100 ml) 
Serum Calcium 
(mg/100 ml) 
Serum Phosphorus 
(mg/100 ml) 
Serum Vitamin A 
(µg/100 ml) 
1 
None 
(n=l 7) 
0. 32
b 
±0.12 
0.16 
±0. 29 
0.14
ab 
±0.09 
0. 16 
±0.07 
0.06 
±0.05 
3.88 
±8.38 
O.Ol
b 
±0.15 
-0.12 
±0.19 
-0.94 
±4.63 
Serum Alkaline P�ospha- 0.70 
tase (mg/100 ml) ±0.26 
Group and Supplement 
2 3 
Ca, P  
(n=l3 ) 
-0.08c 
±0.14 
o. 4o 
±0. 34 
0.32
a 
±0.10 
0.19 
±0.08 
-0.02 
±0.06 
11. 92 
±9.58 
-0.08
b 
±0.17 
-0.67 
±0.22  
7.78 
±5.51 
1.14 
±0.29 
F 
(n=l8) 
0.35
b 
±0.12 
0.56 
±0. 29 
0.07
ab 
±0.09 
0. 26 
±0.06 
0.16 
±0.05 
-2.61 
±8.14 
-0.09
b 
±0.15 
-0. 31 
±0.19 
3.12 
±4.50 
1.51 
±0.25 
4 
F, Ca, P, 
Vitamins 
(n=l2) 
1.05
a 
±0.14 
0.2 1 
±0.35 
-0.17
b 
±0.11 
0.14 
±0.08 
0.15 
±0 . 06 
3.66 
±9.97 
-0.BO
a 
±0.18 
-0.63 
±0.2 3 
11.77 
±5.51 
1.14 
±0.31 
1 
Difference equals final minus initial measurement by subj ect. 
2values expressed as mean ±  SE. 
3Means in a row without a common superscript are significantly 
different from each other at P<0.05. 
4Inorganic phosphorus released from glycerophosphate substrate 
in 1 hour at 37 °. 
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was . also increased significantly in Group 4 o The multiple-range test 
revealed a significant . difference between the increase.in serum level 
of total protein experienced by Group 2 and - the decrease registered by 
Group 4 o  Neither of the changes by Groups 2 or 4 was , _significantly 
different from Group 1 which received no supplement or from Group 3 
which received fluoride (Table 17) � 
Se�um calcium (P < O o OOl) and phosphorus (P < 0. 01) decreased 
significantly between the initial and final tests in Group 4 as indi­
cated in Table 16 0 Group 3 also showed a decrease - in serum phosphorus 
during the same period (P < 0 .05). The decrease in serum calcium in 
Group 4 was significantly greater (P < O o 05) than changes by any of the 
other groups (Table 17) o  The changes in serum phosphorus of the 4 
groups were not significantly different from each other o 
Group 4 axperienced a significant (P < O o Ol) increase in serum 
vitamin A during the supplemental period, but the multiple-range test 
revealed that this change . was not significantly different from those 
of the other groupso 
Alkali�e phosphatase activity increased in all groups g in . Group 
1 (P < O o OOl) , in Group 2 (P < Oe Ol) � in Group 3 (P < Oo OOl) j and in 
Group 4 (P < O o 05) e The multiple-range test . (Table 17 ) showed that 
the increases . by the groups were not significantly different from each 
other � however o Neither blood hemoglobin .nor serum cholesterol changed 
signifi�antly between the initial and final tests for any of the groups o 
Metabolic Balances and Urinary Constituents 
Of the 16 women who were evaluated metabolically at . the initial 
test period, only 12 were able to participate in the balance phase of 
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the study at all 3 evaluation periods. However, 3 of the . 4 women with 
incomplete balance data were present at 2 of the test periods a These 
3 women had all been assigned to the unsupplemented diet (Group l) o 
The mean utilization of nitrogen is shown ·by group in Table 18 
and by individual subject in Table 22 in Appen�ix C o All participants 
in the metabolic studies were in positive apparent nitrogen balance at 
the initial and final test periods . However, nitrogen intake tended to 
decrease during the study with both intake and balances being lowest at 
the intermediate test period o 
Utilization of calcium is shown by group in Table 19 and by in­
dividual · participant in Table 23  in Appendix C .  Calcium intakes de­
creased slightly at the final test period in Groups · ! and 3 which did not 
receive calcium phosphate supplements o The calcium intakes of those in 
Groups 2 and 4 were higher at the intermediate and final test periods 
than were intakes of those . in the groups where calcium supplements were 
not provided a Large quantities of calcium were recovered from the feces 
of those in Group 2 .  Mean urinary calcium decreased in all groups when 
final measurements were compared to initial valueso A significant neg­
ative correlation (P < O a OOOl) was found between fecal calcium and cal­
cium -balance on an overall basis and within each group o 
Apparent .phosphorus balances were decreased during the course of. 
this study in Groups l j 2, and 3 �  Group 4 which received fluoride in 
addition to calcium phosphate showed an increase in its mean apparent 
phqsphorus balance as indicated in Table 20 0 All groups were in positive 
balance at the initial test period, but Group 2 was in negative balance 
at .the final period although each participant in that group received 360 
73 
TABLE 18 
NITROGEN UTILIZATION AT THE THREE TEST PERIODS BY GROUP 
Grou:12 and Su:12:12lement 
2 3 4 
F,Ca,P 
None . 1 ..,,.�a., P F Vitamins 
(n=4) (n=3) (n=4) (n=4) 
Intake (g/day) 
7. 23 2 Initial 8. 83 , 10 . 11 9.52 
±0.96 ±0. 72 ± 2.55 ±0.95 
Intermediate 6.16 5.99 9.19 7.55 
±1. 75 ±0 .  77 ±2. 25 ±1. 20 
Final 5 . 38 7.85 9. 75 7. 70 
±0.55 ±0 .  74 ±1.59 ±0.76 
Urinary (g/day) 
Initial 4. 98 5.65 7.18 5.94 
±0.98 ±0.52 ±1.36 ±0 .  71 
Intermediate 3.-91 4.49 6.59 6.62 
±1. 27 ±0.50 ±1.49 ±2.40 
Final 3.78 5.49 6.86 4.68 
±0.47 ±0.42 ±0.76 ±0 . 81 
Fecal (g/day) 
Initial 0.44 0.69 0.76 0.84 
±0. 09 ±0.39 ±0 . 10 ±0 . 09 
Intermediate 0.41 0 . 70 1 . 28 1 .  02 
±0 . 17 ±0.16 ±0.53 ±0 . 12 
Final 0 . 35 o .  89 1.04 o .  70 
±0.07 ±0 .  20 ±0.26 ±0 . 11 
Balance (g/day) 1 . 81 2.50 2.18 2.73 
±0. 38 ±0 . 22 ±0.98 ±0.41 
Intermediate 1 . 85 0.80 1 .  32 -0 . 10 
±0 . 62 ±0. 49 ±0.43 ±1.41 
Final 1 .  25 1 . 48 1 . 85 2.33 
±Q.Q2 +Q.17 +Q. 78 ±Q, 4S 
1 
For Group 1 n equals 3 and 2 for the intermediate and final test 
periods, respectively. 
2Mean ± SE . 
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TABLE 1 9 
CALCIUM UTILIZATION AT THE THREE TEST PERIODS BY GROUP 
Grouf and Su:e:element 
1 2 3 4 
F,Ca,P 
None Ca,P F Vitamins 
(n=4)1 (n=3) (n=4) (n=4) 
Intake (mg/day) 
617
2 
Initial 757 885 786 
±37 ±102 ±265 ±66 
Intermediate 485 951 770 1037 
±3 ±48 ±236 ±82 
Final 596 1124 850 1106 
±46 ±64 ±195 ±76 
Urinary (mg/day) 
Initial 117 144 99 116 
±32 ±61 ±17 ±37 
Intermediate 42 61 65 80 
±16 ±7 ±12 ±24 
Final 48 69 70 60 
±22 ±33 ±24 ±23 
Fecal (mg/day) 
Initial 677 424 715 896 
±61 ±220 ±81 ±216 
Intermediate 390 811 1095 859 
±120 ±282 ±419 ±77 
Final 589 1582 960 708 
±29 ± 293 ±180 ±79 
Balance (mg/day) 
Initial -177 188 71 -2 26 
±75 ±251 ±210 ±171 
Intermediate 53 78 -390 98 
±108 ±321 ±195 ±102 
Final -40 -528 -179 338 
±96 :!293 ±74 ±131 
1 For Group 1 n equals 3 and 2 for the intermediate and final 
test periods, respectively. 
2Mean ± SE. 
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TABLE 20 
PHOSPHORUS UTILIZATION AT TI!E THREE TEST PERIODS BY GROUP 
Intake (mg/day ) 
Initial 
Intermediate 
Final 
Urinary (mg/day) 
Initial 
Intermediate 
Final 
Fecal (mg/day) 
Initial 
Intermediate 
Final 
Balance (mg/day) 
Initial 
Intermediate 
Final 
None 1 
(n=4) 
880
2 
±41 
711 
±12 3 
719 
±63 
3 23 
±23 
242 
±55 
272 
±10 
374 
±63 
22 7 
±56 
329 
±14 
182 
±50 
242 
±127 
119 
±87 
Group and Supplement 
2 . 3 
Ca ,P  
(n=3) 
964 
±68 
1070 
±90 
1280 
±102 
443 
±100 
418 
±48 
501 
±111 
262 
±117 
528 
±187 
1031 
±189 
260 
±92 
124 
±440 
-251 
+176 
F 
(n=4)  
1165 
±266 
1035 
±264 
· 1145 
±190 
485 
±50 
590 
±12 3 
511 
±26 
390 
±41 
638 
±264 
622 
±130 
290 
±201 
-193 
±142 
12 
+54 
4 
F , Ca ,P 
Vitamins 
(n=4)  
11-02 
±63 
1203 
±125 
1238 
±93 
396 
±43 
445 
±42 
448 
±117 
425 
±43 
509 
±34 
443 
±69 
281 
±71 
250 
±86 
347 
+132 
1 For Group 1 n equals 3 and 2 for the intermediate and final 
test periods , respectively . 
2Mean ± SE . 
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mg of phosphorus in supplemental form.  Individual utilization of phos­
phorus is shown in Table 24 in Appendix C .  
Urinary constituents evaluated as part of the metabolic studies 
are shown in Table 21 by group and in Table 25 in Appendix C by in­
dividual participant o Mean excretion of hydroxyproline decreased by 36% 
in Group 1 during the study but remained stable in the other 3 groups . 
Maximum variation in the mean excretion of creatinine was an 
increase of 15% in Group 2 .  Creatinine excretion increased by 
6% in Group 3 and was unchanged in Groups 1 and 4 o 
TABLE 21 
URINARY CONSTITUENTS AT THE THREE TEST PERIODS BY GROUP 
None 
1 
(n=4) 
Hydroxyproline (µg/24 hours) 2 
Initial 23. 4 
Intermediate 
Final 
Creatinine (mg/24 hours) 
Initial 
Intermediate 
Final 
±4. 7 
21. 8 
±8. 4 
14. 8 
±0. 2  
537 
±109 
594 
±147 
519  
±148 
Group and Supplement 
2 3 
Ca , P  
(n=3) 
25. 0 
±3. 8 
24. 1 
±1. 8 
26. 5 
±3. 3 
583 
±23 
703 
±SO 
670 
±37 
F 
(n=4) 
23. 1 
±3. 0 
24 . 8  
±4. 3 
23. 4 
±4. 3 
646 
±92 
727 
±98 
688 
±24 
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4 
F , Ca ,P  
Vitamins 
(n=4) 
22. 1 
±2.8 
26. 3 
±9. 3 
21. 4 
±5. 4  
545 
±64 
634 
±115 
550 
±97 
1 
For Group 1 n equals 3 and 2 for the intermediate and final 
test periods , respectively. 
2 
Mean ± SE. 
CHAPTER V 
DISCUSSION 
I .  NUTRITIONAL STATUS PRIOR TO DIETARY SUPPLEMENTATION · 
Bone Density 
Previous studies conducted by the Department of Nutrition in the 
College of Home Economics at the University of Tennessee , Knoxville , 
utilizing the bone densitometer described by Williams and Mason (103) 
and involving females aged 3 to 90 years , showed that bone density 
indices ranged from 0 . 72 to 1 . 21. Odland et al . (30) reported that 
from a survey of 296 females aged 3 to 90 years , bone density indices 
increased from a mean index of 0 . 72 for preschool girls aged 3 to 5 
to a mean index of 1 . 10 for adolescents aged 16 to 20.  Bone density 
indices continued to increase throughout the early adult years and 
the greatest index , 1 . 21,  was exhibited by women aged 41 to 50 years . 
Thereafter the bone density index decreased to 0 . 74 for women 80 
to 90 years of age . 
A comparison of bone density indices obtained in the present 
study with those from other laboratories is complicated by the 
variation in standards and units of measurement , the particular bone 
of the skeleton selected for evaluation , methods of compensation for 
flesh , and lack of established norms for quantities of bone at various 
age levels (104) .  Although absolute values cannot be compared with 
those from different laboraties , bone density trends may be observed . 
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Decreases in bone density with advancing age as observed in this 
study have also been reported by Morgan et al . (29) o Additional 
evidence that adult women lose bone as they age has been provided 
by Arnold et · al.. ·(105) from their analysis of bone for ash .. 
In -addition to reduction in bone density with age , age-associated . 
decrements in .height and weight were observed in this study in agreement 
with the findings of others (43,106,107) 0 
Nutrient Intakes and Blood Constituents 
A unique feature of this study was that nutrients consumed were 
calculated from weighed food intakes .  Most large-scale nutritio� studies 
have derived nutrient intakes from interviews and questionnaires such 
as those used in the Ten-State Nutrition Survey (14), from diet histories 
as employed by Odland et al. (3), or from food records as utilized by Fry 
et . al .  (10) and Bransby and Osborne (108). 
Variations in the activities which participants in the various 
dietary . studies enjoy, their association with other people , the geo­
graphical location where they make -their homes, and the state of their 
general health make comparisons between studies difficult and, on 
occasion, confusing o 
Age related decrements in consumption of protein, calcium, 
phosphorus, and ascorbic acid were observed in this study ; �owever, 
mean nutrient intakes of protein, calcium, and phosphorus compared 
favorably with the recommended allowances (7) .. Fo�d consumed pro­
vided nutrient levels similar to those of women evaluated in other 
studies (4, 10, 14, lO�)o 
Food choices.influenced consumption of iron, 'calcium, vitamin A, 
and ascorbic acid as indicated by the ·lack ·of correlation between 
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consumption of these .nutrients and that of other nutrients obtained from 
food . The consumption of vitamin A ,  however , was related to that of 
ascorbic acid . Food preferences did not appear to alter the consump­
tion of kilocalories , protein , fat , and phosphorus ; regardless of the_ 
foods an ·individual chose to eat , these nutrients were included in her 
daily food intake as indicated by their canonical correlations . 
Mean quantities of nutrients consumed by women in this study 
were neither as high nor as low as other levels which have been reported 
(3 , 5 , 14 , 112).  Intakes of -kilocalories , ir.on , and ascorbic acid were 
below those quantities reconimended by the National Research C�uncil 
(7) . However , a glance at the mean weight , which was 7 kg higher than · 
the mean weight established by National Research Council for adult 
women , as well as higher than means reported by Master et al . (107) , 
Gillum et al . (109) , Durnin (110) , and the Ten-State Nutrition Survey 
(18) suggests that the reduced intake of kilocalories was beneficial 
to these ambulatory but . rather sedentary women . 
The recommended allowance (7) for iron from the food consumed is 
10 mg per day and intakes of 10 mg have been reported by several who 
have studied dietary patterns of aged persons (8 , 10 , 13 , 108 , 109 , 110) . 
The mean consumption of iron by women in this study at 8 . 6 mg daily 
appears to be low ; however , mean hemoglobin levels of 13 . 9  g/ 100 ml 
were within the range of normal (101) . In addition , hemoglobin levels 
lower than 13 . 9 g have been reported by others . Gillum et al . (109) , 
. found a mean of 13 . 4  g/ 100 ml for 296 . women aged 50 to 80 ; Brewer 
et al . (17) reported a mean of 13 . 5  for 52 hospitalized women aged 
44 to 98 . A slightly lower mean of 13 . 3  g/ 100 ml was obtained for 
the 2185 women older than 59 years whose nutritional status was 
assessed in the Ten-State Nutrition Survey (18) o 
Dietary intake of ascorbic acid was lower than the recommended 
allowances _although mean plasma levels were within the lower limits 
of normal . Th� mean value of 35 mg per day consumed by women on 
this study who were not re�eiving vitamin supplements cam� within 
1 mg of meeting two-thirds of the recommended allowance of 55 mg 
(7 ) .  The adequacy of a nutrient at this level has been discussed by 
Whitfield (111) . Ascorbic acid intake by women over 60 years of 
age has been evaluated in several studies . Hospitalized patients 
were found to consume about 30 mg ascorbic acid per day (4 , 112 ) . 
In the Ten-State Nutrition Survey (14) , a mean intake of 67 mg per 
day was observed while Morgan et al . (113) reported a . mean of 86 mg 
per day which was more .than twice as high as the mean intake of 
ascorbic acid in this study . Odland et al . (3 ) found a mean intake 
of 122 mg per day . While still others (6 , 8 , 10 , 13 )  have .reported 
intakes higher tha� that_ observed in this study , it is of interest 
to observe that Bransby and Osborne (108) reported a mean daily 
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intake of only 21 mg for 178 healthy women aged 60 to 80 . A normal 
range of plasma ascorbic acid is Q . 3 to 1 . 5 mg/100 ml ; the mean level 
for women participating in this study exclusive of those on vitamin 
supplements was 0 . 34 mg/ 100 ml . When women who were receiving vitamin 
supplements were include� , the mean plasma level increased to 0 . 52 
mg/100 ml . Either mean is somewhat low when compared to the desirable 
range ; they are also low when compared to means presented from studies 
of other. aged populations . Only Barrows and Beauchene (114) reported 
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a mean of 0 . 43 mg/100 ml which was intermediate between .our supplemented 
and unsupplemented means . A mean level of 0 . 69 mg/100 ml was reported 
for 47 hospitalized women aged 44 to 98 (17}; Brin et al . (16) found 
a mean level of 84 mg/100 ml for 103 women of approximately 73 years . 
Morgan et al . (113) have determined a mean of 1 •. 07 mg/100 ml for 293 
women aged 50 to 75; however, the.range was 0 . 07 _to 2 . 53 mg/100 ml . 
In the Ten-State Nutritional Survey (18), serum ascorbic acid fluc­
tuated with the income index ; a _mean of 0 . 72 mg/100 ml for 326 women 
with a low income index was obtained in contrast to a mean of 1. 08 mg 
for 858 women with a high income index . All women were older than 59 
years . 
Dietary protein, calcium, phosphorus, and vitamin A consumed 
by the women met the recommended allowance for women past 55 years of 
age (7).  Serum levels of the corresponding nutrients were also within 
the ranges of normal (101) . It should be recognized, however, that in 
this study dietary intake was a poor predictor of serum levels of · the 
constituents observed . Serum levels were, in turn, poor predictors 
of physical measurements . The level of a nutrient in serum represents 
the balance between its entrance into and removal from the circulatory 
system (115) . Co�relation between dietary nutrients and serum con� 
stituents would be anticipated only when dietary in�akes were ·low for 
lengthy periods of time . 
The enzyme, alkaline phosphatase, is associated with liberation 
of phosphorus from organic complexes . The units by which the activity 
of the enzyme is estimated are varied and include units devised by King 
and Armstrong, King-Armstrong units, or by Bodansky, Bodansky units 
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(116) . Other units of measurement include IU , units/�iter , and mg of 
phosphorus released per 100 ml serum . When units from othe� studies 
were extrapolated to mg of phosphorus released per 100 mg serum, the 
activ�ty of the enzyme as measured in this study appeared to be low . 
While the activity may be less than that evaluated by other techniques , 
reduced activity appears to be of little concern. A low level of 
enzyme activity recorded for the women suggests that prior to supple­
mentation limited remodeling of bone was occurring . Th� enzyme becomes 
hyperactive in metabolic diseases of the bone such as rickets and 
Osteitis deformans (Paget ' s  disease) .  
II . EFFECT OF SUPPLEMENTATION WITH VITAMINS , CALCIUM 
PHOSPHATE, AND SODIUM FLUORIDE 
The levels of supplements, added to the diets of the subj ects were 
low since dietary intake , unsupplemented , compared favorably with the 
recommended allowances and levels of blood constituents were within the 
ranges of normal. Metabolic balances of nitrogen and phosphorus were 
positiv� and the calcium balance was j ust slightly negative (-52 mg) .  
Fluoride was administered· at a level of 0 . 25 mg/kg body weight/day , 
which was relatively low in contrast to the levels that have been 
utilized in other studies (80 , 81 , 117 , 118). None of the women were 
required to discontinue use of the supplement as a result of adverse 
effects and no symptoms of fluoride toxicity were observed in any of the 
women during the present study .  
Bone Density 
With fluoride therapy , increases in bone as evaluated from 
microradiograph appearances and osteoid tissue measurements of 4 
patients were reported (59, 82) . Similar increases have been noted 
in 1 subject by Cass et al . (118) and in 4 subjects by Bernstein and 
Cohen (81) . In a case study by Rich and Ivanovich (80) an increase 
of approximately 13% in bone density was attained using 40 to 50 
mg fluoride per day . The level employed in this study ranged from 
10 to 30 mg per day . Bernstein and Cohen (81) found that patients 
treated with levels greater than 44 mg fluoride per day exhibited 
lumbar spine x-ray films which showed sharper, thicker , and better 
demarcated cortices with more uniform and thicker trabeculae than 
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were observed in pretreatment films . Jowsey et al . (59) found that 
treatment of 3 patients with sodium fluoride at .levels up to 0 . 77 mg 
F/kg body weight/day resulted in formation of new bone . Administration 
of tetracycline at specific times during the fluoride therapy identi­
fied newly formed bone . Rib biopsies from the 3 patients showed that 
bone formed during the administration of fluoride covered an average 
of 53% of the bone surface. Although bone formation was increased 
to a level much . greater than normal , the new tissue was not always 
adequately mineralized (59) . Later work by Jowsey et al . (83) 
resulted in a recommendation of 50 mg of sodium fluoride (22 . 7  mg F) 
per day accompanied by at least 900 mg of calcium per day and 50 , 000 
IU of vitamin D twice weekly for restoration of bone mass in osteo­
porotic subjects . 
The bone densities of 15 of the 18 subjects increased in this 
study in response to fluoride without the ingestion of calcium 
phosphate and vitamin supplements . When calcium phosphate and vitamin 
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supplements accompanied fluoride, 10 of 12 women increased their bone 
densities . Although deposition of mineral was necessary for increased 
density to be measured, the quality of the bone cannot be described 
since histological .studies were not included . 
Nutrient Intake 
Insignificant changes in mean nutrient consumption from food 
were observed during the study ; when minerals and vitamins were added 
as a part of the supplement regimen, the intake of those nutrients 
was significantly increased . Since Group 4 received supplements of 
calcium, phosphorus, vitamin A, and ascorbic acid, intakes of those 
4 nutrients were significantly increased .  Group 2 experienced signi­
ficant increases in calcium and phosphorus consumption . Since these 
women were already receiving vitamin supplements at the beginning 
of the study and were maintained on them, no significant change in 
their intake was observed . Calcium consumption by the women in Group 3, 
who received fluoride without additional vitamin and mineral supple­
ments, decreased at the final test period ; however, the mean change 
in intake was_ not significantly different from that of Group 1 .  The 
mean amount of dietary calcium consumed by Group 3 in the final test 
period, 761 mg, was only 5% lower than the recommended intake, and it 
seems unlikely that the fluoride supplement was responsible - f·or the 
decrease in calcium consumption . 
Blood Constituents 
Serum levels of both calcium and ph�sphorus decreased in the 2 
groups which received a fluoride supplement ; however, the decrement 
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was significant (P<0 . 05 )  only for Group 4 .  Similar decreases in serum 
calcium accompanying fluoride treatment have been reported by Jowsey 
et al . (59,83), Rich et al . (117) , and Cass et al . (118) . Although the 
decrease in the serum calcium level of Group 4 was significant , the 
final level (9 . 4  mg/100 ml) remained within the range of normal . As 
anticipated, due to supplementation of the diet , those in Group 4 in­
creased their plasma ascorbic acid and serum vitamin A levels signi­
ficantly at the final test period . A decrease .in plasma ascorbic acid 
by those in Group 2 cannot be logically explained . An insignificant 
decrease in serum protein between the initial and final test periods 
was experienced by Group 4 .  Levels of  serum protein increased in 
Groups 1 and 2 and the increase in Group 2 was of such a magnitude 
that the change differed significantly from that of Group 4 .  The 
change by Group 4 was not significantly different from that of the 
other group receiving fluoride (Group 3) . The decrease in serum 
protein levels of Group 4 could not be attributed to fluoride 
supplementation . 
Metabolic Balances 
Several changes were observed in the metabolic balance studies 
although biological variability , innate errors of such studies , and 
the limitation in the number of subjects participating tended to 
obliterate any statistically significant effects . 
The mean nitrogen intake at the initial test period had decreased 
by approximately 14% by the final test period . Decreases occurred not 
only in analyzed nitrogen intake of those participating in the balance 
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studies , but also in the calaulated protein intake of the larger group 
of 60 .  Mean decreases in apparent nitrogen balance were experienced 
·by all 4 group s ,  although 2 of the subj ects  in Group 4 increased 
their balances . None of the part icipants was in negative nitrogen 
balance at the final test period although apparent nitrogen balance 
decreased by 25% during the study . _ 
Administration of calcium_ supplements to Group 2 resulted in 
greater amounts of fecal calcium.  Subj ects in that group lost almost 
30% more calcium in the feces than they were consuming (diet plus 
supplement )  at the final test period . Such los ses are not completely 
illogical since 300 to 800 mg of calcium may enter the intestinal 
tract endogenously each day (119) . The mean positive balance of 
Group 2 decreased from 188 to -528 mg/day . Two of the 3 persons 
experienced drastic increases in fecal calcium. This increase was not 
observed at the intermediate test period . Three members of the group 
receiving only fluoride supplements (Group 3 )  were in negative calcium 
·balance at the initial test period (mean equal to 7 mg/day) and at 
the final test period all 4 members were in negat ive calcium balance . 
At the intermediat e test period the mean apparent calcium balance 
had decreased to -390 mg/day . Balances were les s negative (mean of 
-179 mg) at the final period . Cass et al . (118) observed that with 
fluoride therapy the negativity of calcium balance decreased from 
-300 mg/day to -48 mg/day in 8 months . 
Three members of Group 4 were in negative calcium balance at 
the initial test period with a mean apparent balance of -226 mg/day . 
Balances increased throughout th� study and a final mean apparent 
balance of 338 mg/day was observed . 
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Varying responses to calcium supplements , especially in combina­
tion with sodium fluoride , have been reported . Purves (120) found 
that at 60 mg F/day , 4 of 5 patients changed from negative to 
positive calcium balance in a 3 month period of time ; Rose (84) 
found no change in response to fluoride in a 6 to 12 month period , 
and Bernstein and Cohen (81) reported that calcium balances were 
decreased initially , then became higher with longer fluoride therapy . 
Increasing calcium intake without adding fluoride did not alter 
calcium balances in 3 osteoporotic women to the extent that was 
observed in young non-osteoporotics (67) . Varied response to 
calcium supplements has been described in several additional studies 
(43 ,81 , 117) . 
A correlation (P<0 . 0001) between fecal calcium and calcium 
balance , regardless of calcium intake or bone density , is not 
inconsistent with an age-associated defect in calcium absorption . 
Hurxthal and Vose (121) reported decreased calcium absorption and the 
necessity for consumptio� of large quantities of calcium to maintain 
positive balance in elderly subj ects . Spencer et al . (67) indicated 
that calcium absorption is poor in patients with osteoporosis . 
Phosphorus balances fluctuated in a pattern quite similar to 
that observed for calcium . Decreases in . urinary excre�ion as observed 
in this study with administration of fluoride also have been reported 
by Jowsey et al . (83)  and Spencer et al . (122) . 
Fluoride Overview 
In Group 3 ,  increased bone density was accompanied by decreases 
in the positive balances of nitrogen and phosphorus . Calcium balance 
was slightly negative at the last test period; however , it was less 
negative than it had been at the intermediate period . Rich et al . 
(117) reported a reduced tendency to store calcium during fluoride 
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therapy as compared to storage during calcium therapy ; his patients , 
however , were able to remain in positive calcium - balance with fluoride 
supplementation , in contrast to the results obtained in the present 
study . Spencer et al . (122) found that absorption of calcium did not 
increase when dietary calcium was increased in the presence of fluoride . 
In earlier work , these same authors (69) reported that calcium 
asorption decreased with fluoride therapy in 9 men regardless of 
calcium intake . In this study serum levels of both calcium and 
phosphorus were reduced in those persons receiving fluoride supple­
ments . A similar decrease in blood levels of these nutrients with 
fluoride therapy has been observed by others (59 , 83 , 11� , 118) . 
The lack of a statistically significant increase in bone density 
, by the subj ects r�ceiving vitamins , calcium phosphate,  and sodium 
fluoride supplements was somewhat unexpected (Group 4) . However , 
10 of 12 subj ects increased their bone densities which may be biologi­
cally significant for the individual subj ect . Increases in serum 
ascorbic acid and vitamin A levels were stimulated by the vitamin 
supplements . Serum levels of calcium and phosphorus significantly 
decreased (P< 0 . 01) as was the tendency for Group 3· which re�eived 
the fluoride supplement . Th� mean calcium balance which was negative 
at the onset of supplementati�n was positive 330 mg by the end of 
the study . The positive phosphorus balance was tripled during the 
12 months of supplementation . Perhaps, if supplementation had been 
extended beyond 12 months, statist_ically significant increases in 
bone density would have been observed . 
Increases in bone density. could not be related to changes in 
nutrient intake, blood constituent le�els , or metabolic balances 
measured in this study. Adams et al . (43)  could not relate bone 
loss to similar parameters. While Cass et al . (118) failed to attain 
positive calcium bal�nces with fluoride therapy, biopsy of the iliac 
crest showed greatly increased amounts of osteoid material . 
It has long been known that calcium absorption and its balance 
varies between individuals and periodically in the same person (123 ) .  
It is possible that bone mineral behaves in a similar pattern, thus 
rendering both balance information and bone density measurements 
difficult to interpret. 
The failure to achieve an increase in bone density in Group 4 
of as large a magnitude as that in Group 3 was not expected . It is 
possible that supplementation with calcium and fluoride (Group 4) 
simultaneously, could lead to the formation of insoluble calcium 
fluoride, thus making both elements unavailable to the extent that 
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the salt was formed. It seems quite certain, however, that it was not 
the unavailability of the calcium that was.the -influencing factor. 
Even when the calcium was administered without supplemental fluoride 
(Group 2 )  the increase in bone density obtained was not significant . 
Thus, if the complex formed, it must have been the relative · 
unavailability of the fluoride that was important . That an . increase 
(4%) in bone density was achieved in Group 4 might have been due to 
the partial availability · of the fluoride ion . Free fluoride is known 
to be rapidly absorbed from the intestinal tract (124) . 
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From all indications , fluoride supplementation had no important 
effects on the overall nutritional status of the subjects except for 
improvements in their borie densities . The fact that bone · density was 
most increased in the group receiving fluoride alone as the dietary 
supplement certainly argues in favor of the use of the element in 
the treatment of osteoporosis and/or in the maintenance of bone density 
of elderly women. In addition , it is tempting to speculate that the 
element must serve a unique role in metabolism of bone . 
CHAPTER VI 
SUMMARY 
The nutritional status of 76 women with a mean age of 68 years 
was assessed before and after a 12-month experimental period in which 
diets were unsupplemented or supplemented with fluoride (0 . 25 mg/kg 
body weight /day) , with calcium phosphat e (464 mg calcium and 360&_mg 
phosphorus daily ) ,  or with a combination of fluoride , calcium phos­
phate and vitamins . Approximately 18 women over 50 years of age were 
assigned to each group . 
Prior to supplementation , weighed dietary intakes were evaluated 
for 8 nutrients . Mean energy intake per day was 1519 kilocalories with 
15% derived from protein and 36% from fat . Mean daily intakes included 
797 mg of calcium, 1000 mg phosphorus , and 8 . 6 mg of iron . Mean 
dietary intakes of the 59 women who were not receiving vitamin supple­
ments were 5800 IU and 35 mg for vitamin A and ascorbic acid respec­
tlvely . The mean intakes of vitamin A and ascorbic acid increased by 
75 and 135% respectively when values for 17 women receiving dietary 
supplements of these 2 nutrients were included. 
Blood levels of 10 constituents were also determined.  Mean 
blood hemoglobin was 13 . 9  g/ 100 ml and serum calciu� and. phosphorus 
levels had means of 9 . 60 and 3 . 35 mg/100 ml , respectively . A mean 
of 1 . 92 mg inorganic phosphorus was released from a glycerophosphate 
substrat e by alkaline phosphatase , while the mean cholest erol level 
was 222 mg per 100 ml . Mean serum levels of total prot ei� and albumin 
were 6 . 7 7 and 3 . 6 7 g/ 100 ml , respectively , and the mean A/G ratio was . 
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1. 22 . At the initial test the plasma ascorbic acid averaged 0 .,34 mg/100 
ml and serum vitamin A, 50 . 4  µ g/100 ml; the means were increased by 
50 and 2% respectively when values for the 17 subjects receiving 
vitamin supplements were included . In addition, mean excretion of 
hydroxyproline was 24 . 06 µg/24 hours and creatinine excretion was 
607 mg/24 hours . 
The mean bone density index of the left phalanx 5-2 was 0 . 819 g 
equivalents of alloy per cc of bone, while mean height and weight were 
156 . 3 cm and 65. 4 kg, respectively . 
Canonical correlations showed an age-associated decrease in bone 
density, height, weight, and intake of protein, calcium, phosphorus, 
and ascorbic acid. Significant correlations existed between dietary 
intakes of energy, protein, fat, and phosphorus and also between 
vitamin A and ascorbic acid consumption . The initial measurements 
indicated that the women represented a typical geriatric population 
with reduced nutrient intakes, bone densities, heights, and weights. 
Although minor differences in nutrient intakes and blood levels 
occurred in the groups receiving fluoride, the changes could not be 
attributed to fluoride supplementation . Consumption of calcium 
decreased in the group which received fluoride, although the final 
mean intake was 761 mg per day . In the group receiving fluoride in 
combination with calcium phosphate and vitamin supplements, increases 
in plasma ascorbic acid and serum vitamin A and decreases in serum 
total protein, calcium and phosphorus were obtained .  Nevertheless, 
all values remained within normal ranges . 
Supplementation with fluoride resulted in a significant 10% 
increase ·in bone density and fluoride in combination with .calcium 
phosphate ·and vitamins produced a 4% increase in bone density . 
Insignificant increases in bone density were observed when the 
diet was unsupplemented (2%) or supplemented with calcium phosphate 
(2 . 5%) . 
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Metabolic balance studies revealed mean increases in balances 
of calcium and phosphorus by those receiving fluoride in combination 
with calcium phosphate and vitamins • .An age-associated defect in 
calcium absorption was indicated in all experimental groups . Nitrogen 
balances of all women remained positive throughout the study . Changes 
in neither calcium nor phosphorus balances correlated with those in 
bone density . Positive balances of these nutrients were shown when 
fluoride accompanied the supplements of calcium, phosphorus, and 
vitamins but bone density decreased in 2 of the 4 subjects in that 
balance group . All members of the group receiving fluoride exhibited 
negative balances of calcium and phosphorus while bone density 
increased . 
No adverse effects or fluoride toxicity symptoms were observed in 
any of the women during the study .  The biological significance of a 
decrease in serum calcium has not been elucidated ; a shift of serum 
calcium to bone, or a reduction in calcium mobilized from bone (possibly 
lowering serum calcium), may be advantageous . Increases in bone 
density in response to fluoride without alterations in dietary intake 
or serum levels of the constituents evaluated in this study , other 
than serum calcium, tends to encourage further exploration of the 
prophylactic as well as therapeutic benefits of low-level fluoride 
supplementation . 
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APPENDICES 
APPENDIX A 
LETTERS AND CONSENT FORMS 
Dear {Patient) 
The Nutrition Department at The University of Tennessee is 
inviting you to participate in a nutrition study . The purpose of 
the study is to evaluate the medical-nutritional status of a group 
of selected women patients at Eastern State Psychiatric Hospital and 
then to evaluate the effectiveness of dietary supplements in changing 
their nutritional status . 
Participation in the study consists of allowing us to assign you 
to a group receiving for twelve months either the regular hospital diet 
or the hospital diet supplemented with vitamins and/or minerals and to : 
1 .  Record food intake for a week 
2 .  Take a blood sample _for analysis 
3 .  Collect urine and fecal output for a week 
4 .  Determine bone density by a harmless x-ray procedure 
similar to dental x-rays 
The initial tests (1 , 2, 3 , 4 ) will be made in January and will be repeated 
at six month intervals . 
The dietary supplementation will be in the form of multiple vita­
min and mineral capsules . The mineral supplements in which we are 
particularly interested are calcium phosphate and sodium fluoride . 
Calcium phosphate has been frequently added to the diets of the elderly 
to prevent bone loss . Recent studies have indicated that sodium fluoride 
added to the diet may decrease the amount of mineral lost from bone 
during aging . Sodium fluoride has long been known to reduce tooth decay 
when added to drinking water . With age, bones generally become weaker 
and they may suddenly break . We feel that supplementation of the diet 
with sodium fluoride may be of value in reducing bone mineral losses 
and susceptibility ·to f�actures . The level of fluoride used will be well 
below that which has caused any tox�c effects . In rare instances 
supplementation of the diet with high levels of sodium fluoride has pro­
duced side effects s�ch ·as nausea and joint pain . However , the maj ority 
of people who have received sodium fluoride indicate . that the mineral 
is well tolerated and that it tends to reduce j oint pains . 
We . think this study will provi4e very useful information con- . 
cerning the nutritional status of older people and we hope that you 
will desire to help us . 
Sincerely, 
107 
Dear 
The Department of Nutrition at The University of Tennessee is 
making a study of the nutritional status of elderly women in which 
-------- has indicated a desire to participate . Enclosed is 
a copy of a letter explaining the study, which we have given to her . 
108 
The study has also been explained to her personally . A copy of a 
signed consent form indicating her desir� to participate is also 
enclosed . We need your permission for her to participate . The study 
will interfere very little with t�e schedule which she is now follow­
ing at Eastern State Psychiatric Hospital . To give us your permission, 
please sign the Permission Form in the space indicated by the red 
X, write in the date, and return the form to us in the enclosed self­
addressed and stamped envelope at your earliest convenience . If you 
have questions regarding the study, please contact us by writing to : 
Dr . Roy E .  Beauchene 
Department of Nutrition 
The University of Tennessee 
Knoxville, Tennessee 37 916 
If . you prefer, you may call the Nutrition Department at The University 
of Tennessee , Knoxville (974-3491) . Dr . Beauchene , Mrs . Ma�on , Miss 
Whitfield, or Miss Thompson will be glad to answer your questions . 
Thank you very much for your interest and cooperation . 
Sincerely, 
Sue Thompson 
CONSENT FORM 
I, , would like to participate in the University of 
109 
Tennessee, Department of Nutrition, study. I understand that I will 
receive either the regular hospital diet or the hospital diet supple­
mented by vitamins or minerals and that (1) my food intake will be 
recorded for a week, (2) a blood sample will be taken , (3) urine and 
feces will be collected for a week, and (4) bone density will be 
determined by a painless and harmless x-ray procedure. I also 
understand that these tests will be repeated at six month intervals 
during the study. 
Date ---------------
PERMISSION FORM 
I am willing for to participate in the University of 
Tennessee, Department of Nutrition, study. I understand that she 
will be given either the regular hospital diet or the hospital diet 
plus a vitamin or mineral supplement and that (1) food intake will 
be recorded for a week, (2) a blood sampl� will be taken, (3) urine 
and feces will be collected for a week, and (4) bone density will 
be determined by a painless and harmless x-ray procedure . I also 
understand that these tests .will be repeated at six month intervals 
during the study. 
APPENDIX B 
SYSTEM FOR DETERMINING THE WEIGHT OF FOOD SERVED AND CONSUMED 
Sheet 1 
Food Served 
Lunch 6/1/71 
Plate Plus Bowl Plus 
Name of Fried Buttered Green Cole Apple 
Subject Plate Fish Potatoes Beans Slaw Bowl BettI Bread Milk 
N g g g g N g g g 
Green 1 1 493 612 660 723 1
2 
289 25 1903 
Sheet 2 
Food Unconsumed 
Lunch 6/1/71 
Plate Plus Bowl Plus 
Name of Fried Buttered Green Cole Apple 
Subject Plate Fish Potatoes Beans Slaw Bowl Betti Bread Milk 
N g g g g N g g g 
Green 11 444 400 400 400 12 206 0 6 
Sheet 3 
Food Eaten 
Lunch 6/1/71 
Name of Fried · Buttered Green Cole Apple 
Subject Plate Fish Potatoes Beans Slaw ..Bowl Betti Bread Milk 
g g g g N g g g 
Green 11 49 119 48 63 1
2 
83 2 5 185 
1 
Plate #1 weighed 400 g. 
2 
Bowl #1 weighed 200 g. 
3 Paper cup (8 oz. ) weighed 5 g. 
1 10 
APPENDIX· C 
NUTRIENT UTILIZATION TABLES AND STATISTICAL TABLES 
TABLE 22 
NITROGEN UTILIZATION BY INDIVIDUAL SUBJECTS 
Subject Test Urinary Fecal 
number period Intake loss loss Balance 
---------------- g/day ---------------�-
Group 1 (no supplement) 
1 Initial 8. 99 7. 52 0. 58 0. 89 
Intermediate 9. 65 6. 38 0. 28 2 � 99 
2 Initial s. 02 2. 96 0. 17 1. 89 
Intermediate 4. 07 2. 19 0. 18 1. 70 
3 Initial 6. 23 4. 04 a. so . 1. 69 , 
Final 4. 83 3. 32 o. 28 1. 23 
4 Initial 8. 68 s. 38 0. 53 2. 77 
Intermediate 4. 77 3. 15 o. 76 0. 85 
Final 5. 94 4. 25 o. 42 1. 27 
Group 2 (Ca, � supplement) 
5 Initial 7. 38 4. 65 0. 36 2. 37 
Intermediate 5. 43 3. 84 0. 58 L OO 
Final 6. 88 4. 83 o. 59 1. 46 
6 Initial · 9. 57 6. 40 o. 24 , 2. 93. 
Intermediate 7. 51 5. 48 a. so 1. 53 
Final 9. 31 6. 26 1. 27 1. 79 
7 Initial 9. 54 5. 89 1. 46 2. 19 
Intermediate 5. 04 4. 16 1. 02 -0. 14 
Final 7. 35 5. 38 0. 80 1. 18 
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Subject 
number 
Group 3 
8 
9 
10 
11 
Group 4 
12 
13 
14 
15 
Test 
period 
(F supplement) 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
(F,Ca,P Vitamins 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
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TABLE 22 (continued) 
Urinary Fecal 
Intake loss loss Balance 
---------------- g/day -----------------
16.50 10.49 Q.92 5.09 
16.32 10.99 2.80 2.54 
14.10 8.11 1.82 4.16 
8.10 5.67 a. as 1.58 
6.79 5.07 1.12 Q.61 
8.74 6.62 Q.73 1.39 
9. 71 8.21 0.46 1.04 
7.56 5.81 o .  42 1.33 
9.62 7.90 0.72 1.00 
6.15 4.35 0.80 1.00 
6.09 4.50 0.76 0.81 
6.55 4.79 0.91 Q.84 
supplement 
11. 99 7.47 1.04 3.48 
10.80 13.79 1.03 -4.02 
8.55 5.38 0.38 2.79 
8.01 5.47 0.95 1.59 
6.40 5.14 0.97  0.28 
9.38 6.47 0. 72 2.20 
8.02 4.19 0.69 3.14 
5.26 3.82 0.75 0.69 
6.15 4.14 0.88 1.12 
10.06 6.65 o .  70 2. 71 
7.74 3.74 1.33 2.69 
6. 71 2. 71 Q.80 3.20 
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TABLE 23 
CALCIUM UTILIZATION BY INDIVIDUAL SUBJECTS 
Subject Test Supple-
1 
Urinary Fecal 
number period ment Intake loss loss Balance 
------------------- mg/day ------------------
Group 1 (no supplement) 
1 Initial 560 149 722 -311 
Intermediate 490 74 196 220 
2 Initial 573 44 560 -31 
Intermediate 481 20 609 -148 
3 Initial 722 187 600 -65 
Final 551 69 618 -135 
4 Initial 613 87 827 -301 
Intermediate 483 32 366 86 
Final 642 26 560 56 
Group 2 (Ca1P supplement) 
5 Initial 603 41 331 231 
Intermediate 464 888 46 866 -25 
Final 464 1020 26 1752 -757 
6 Initial 951 253 97 601 
Intermediate 464 1045 68 297 680 
Final 464 1240 136 1984 -881 
7 Initial 716 137 845 -266 
Intermediate 464 920 68 1271 -418 
Final 464 1111 46 1012 54 
Subject 
number 
Group 3 
8 
9 
10 
11 
Group 4 
12 
13 
14 
15 
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TABLE 23 (continued) 
Test Supple-
1 
Urinary Fecal · 
period ment Intake loss loss Balance 
-------------------- mg/day ------------------
(F supplement) 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
(F,Ca,P Vitamins 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
1680 
1476 
1431 
600 
521 
721 
598 
525 
623 
662 
556 
627  
supplement) 
901 
464 1246 
464 1196 
892 
464 1004 
464 1270 
636 
464 850 
464 945 
716 
464 1047  
464 1013 
1 ·  
Supplement included. 
103 893 684 
64 2323 -911 
114 1459 -142 
112 751 -263 
100 752 -331 
110 669 -58 
131 502 -35 
54 436 34 
34 985 -396 
50 715 -103 
42 868 -354 
21 725 -119 
107 778  16 
81 771 393 
54 489 653 
99 1526 -733 
135 938 -69 
123 700 448 
218 541 -123 
87 693 71 
50 822 72 
40 740 -64 
17 1033 -3 
14 823 177 
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TABLE 24 
PHOSPHORUS UTILIZATION BY INDIVIDUAL SUBJECTS 
Subject Test Supple-
1 
Urinary Fecal 
number period ment Intake loss loss Balance 
------------------ mg/day ---------------------
Group 1 (no supplement) 
1 Initial 932 340 516 76 
Intermediate 957 333 129 496 
2 Initial 763 262 277 224 
Intermediate 571 141 325 105 
3 Initial 884 322 260 302 
Final 656 282 343 32 
4 Initial 940 · 369 443 128 
Intermediate --- 605 252 226 127 
Final 782 261 315 206 
Group 2 (Ca,P supplement) 
5 Initial 828 256 234 339 
Intermediate 360 973 324 566 83 
Final 360 1113 304 1239 -430 
6 Initial 1039 599 75 365 
Intermediate 360 1250 480 186 584 
Final 360 1466 690 1200 -424 
7 Initial 1026 475 477 75 
Intermediate 360 986 450 831 -294 
Final 360 1261 508 654 100 
Subject 
number 
Group 3 
8 
9 
10 
11 
Group 4 
12 
13 
14 
15 
1 
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TABLE 24 (continued) 
Test Supple- 1 Urinary 
Fecal 
period ment Intake loss loss Balance 
-------------------- mg/day -------------------
(F supplement) 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
(F,Ca,P Vitamins 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial · 
Intermediate 
Final 
1952 
1823 
1694 
910 
766 
1009 
1002 
836 
1060 
796 
716 
817 
supplement) 
1228 
360 1531 
360 1330 
1102 
360 1081 
360 1453 
930 
360 953 
360 1048 
1148 
360 1247 
360 1122 
Supplement included. 
575 490 887 
957 1417 -551 
578 955 162 
467 425 18 
507 486 -227 
529 470 10 
548 315 139 
452 244 140 
464 692 -96 
350 330 116 
446 404 -134 
474 370 -27 
410 377 441 
523 552 456 
351 309 670 
458 551 93 
513 413 156 
796 421 235 
271 360 299 
373 510 70 
358 635 54 
445 413 290 
371 560 316 
287 406 429 
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TABLE 25 
URINARY CONSTITUENTS FOR INDIVIDUAL SUBJECTS 
Subject Test 
number period Hydroxyproline Creatinine 
µg/day mg/day 
Group 1 (no supplement) 
1 Initial 37. 27 820 
Intermediate 38. 60 870 
2 Initial 16. 64 320 
Intermediate 13. 94 368 
3 Initial 18. 16 426 
Final 15. 02 371 
4 Initial 21. 64 583 
Intermediate 12. 89 545 
Final 14. 53 667 
Group 2 (Ca,P supplement) 
5 Initial 17. 41 564 
Intermediate 20. 49 780 
Final 31. 45 660 
6 Initial 28.91 630 
Intermediate 26.59 719 
Final 27. 77 739 
7 Initial 28.56 556 
Intermediate 25.18 609 
Final 20.22 612 
Subject 
number 
Group 3 
8 
9 
10 
11 
Group 4 
12 
13 
14 
15 
TABLE 25 (continued) 
Test 
period 
(F supplement) 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
(F,Ca,P Vitamins supplement) 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Initial 
Intermediate 
Final 
Init ial 
Intermediate 
Final 
Hydroxyproline 
}Jg/day 
27. 28 
36. 15 
32. 84 
25. 52 
25. 34 
26. 72 
25. 48 
22. 39 
21. 45 
14. 01 
15. 40 
12. 44 
25. 59 
31. 27 
30. 49 
26.45 
50. 41 
31.12 
14. 30 
12. 77 
12.61 
22.17 
10. 72 
11. 56 
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Creatinine 
mg/day 
627 
1010 
707 
504 
574 
687 
910 
619 
736 
544 
706 
621 
714 
939 
633 
447 
684 
784 
445 
451 
422 
574 
462 
363 
TABLE 26 
LEAST SQUARES ANALYSIS OF VARIANCE FOR DIFFERENCE
! 
IN . 
PHYSICAL MEASUREMENTS BY GROUP 
Source of Variation 
1 2 Bone Density Index 
Group 
Error 
Total 
3 2 Bone Density Index 
Group 
Error 
Total 
Height (cm) 
Group 
Error 
Total 
Weight (kg) 
Group 
Error 
Total . 
df 
3 
56 
59 
3 
56 
59 
3 
56 
59 
3 
56 
59 
ss 
0. 0549 
0. 4602 
0. 5151 
0. 0008 
0. 3323 
0. 3331 
18. 54 
175. 66 
194. 20 
210. 79 
2306. 99 
2517. 78 
MS 
0. 0183 
Q. 0082 
0. 0003 
0. 0059 
6. 18 
3. 14 
70. 26 
41. 20 
119 
F 
2. 2282
4 
0. 04455 
1 . 91oi 
1 
Difference equals final minus initial measurement by subj ect. 
2 
Gram equivalents of alloy per cc of bone. 
3 Difference equals intermediate minus initial measurement by 
subj ect. 
4 Significant, P<0. 09. 
5Not significant, P>0. 10. 
6
Not significant, P>0. 05. 
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TABLE 2 7 
LEAST SQUARES ANALYSIS OF VARIANCE FOR DIFFERENCE
! 
IN DIETARY 
MEASUREMENTS BY GROUP 
Source of Variation 
Energy (kcal) 
Group 
Error 
Total 
Protein (g) 
Group 
Error 
Total 
Fat (g) 
Group 
Error 
Total 
Calcium (mg) 
Group 
Error 
Total 
Phosphorus (mg) 
Group 
Error 
Total 
Iron (mg) 
Group 
Error 
Total 
Vitamin A (IU) 
Group 
Error 
Total 
Ascorbic Acid (mg) 
Group 
Error 
Total 
df 
3 
56 
59 
3 
56 
59 
3 
56 
59 
3 
56 
59 
3 
56 
59 
3 
56 
59 
ss 
308238 
83 2 2829 
8631067 
63 
11521 
11584 
82 
14918 
15000 
3070010 
2324249 
5394259 
1747694 
3313539 
50612 33 
0. 43 
375. 24 
3 75. 67 
3 6196663836 
55 1753316484 
58 7949980320 
3 
55 
58 
362648 
15182 
377830 
MS 
102746 
148622 
21 
206 
27 
266 
1023337 
41504 
582565 
59170 
0. 14 
6. 70 
2065554612 
31878482 
120883 
276 
F 
0. 6913
2 
0. 10202 
0. 1024
2 
24. 65613 
0. 02152 
64. 79463 
437. 93013 
1 
Difference equals final minus initial measurement by subject. 
2
Not significant, P>0. 05. 
3 
Significant, P<0. 0001. 
TABLE 28 
LEAST SQUARES ANALYSIS OF VARIANCE FOR DIFFERENCEl IN 
BLOOD CONSTITUENTS BY GROUP 
Source of Variation df ss MS 
Blood Hemoglobin (g/100 ml) 
Group 3 1. 6566 0. 5 5 2 2  
Error 56 82. 8108 1. 4788 
Total 59 84. 4673 
Plasma Ascorbic Acid (mg/100 ml) 
121 
F 
0. 3734
2 
Group 3 8. 0188 2. 6729 10. 8343
5 
Error 55 13. 5690 0. 2 467 
Total 58 21. 5878 
Serum Total Protein (g/100 ml) 
Group 3 1. 54 0. 51 
3 ! 70783 Error 56 7. 77 0. 14 
Total 59 9. 31 
Serum Albumin (g/100 ml) 
Group 3 0. 1218 0. 0406 0. 5234
2 
Error 56 4. 3440 o .  0776 
Total 59 4. 4658 
Serum A/G Ratio (g/100 ml) 
Group 3 0. 32 35 0. 1078 2. 1460
2 
Error 56 2. 8138 0. 0502 
Total 59 3. 1373 
Serum Cholesterol (mg/100 ml) 
Group 3 1596 532 0. 44602 
Error 56 66812 1193 
Total 59 68408 
Serum Calcium (mg/100 ml) 
Group 3 5. 5978 1. 8659 
4. 75804 
Error 56 21. 9615 0. 392 2  
Total 59 27. 5593 
Serum Phosphorus (mg/100 ml) 
Group 3 3. 0930 1. 0310 1. 64412 
Error 56 35. 1168 0. 6271 
Total 59 38. 2098 
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TABLE 28 (continued) 
Source of Variation df ss MS F 
Serum Vitamin A (µg/100 ml) 
Group 3 1296 43 2 
L 185i 
Error 55 2 0048 364 
Total 58 21344 
Serum Alkaline Phosphatase (mg/100 ml) 6 
Group 3 5.7634 1. 9211 1. 7017
2 
Error 56 63. 2209 1.1289 
Total 59 68.9843 
1 
Difference equals final minus initial measurement by subj ect. 
2 
Not significant, P> 0.05. 
3 Significant, P<0. 02. 
4 
Significant, P< 0.005. 
5 
Significant, P<0.0001. 
6 Inorganic phosphorus released from glycerophosphate substrate 
in 1 hour at 37 °. 
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